Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
Tax	B-protein
induction	O
of	O
NF-kappaB	B-protein
involves	O
activation	O
of	O
the	O
IkappaB	B-protein
kinase	I-protein
alpha	I-protein
(	O
IKKalpha	B-protein
)	O
and	O
IKKbeta	B-protein
cellular	B-protein
kinases	I-protein
.	O

Tax	B-protein
corresponds	O
to	O
a	O
40-kDa	B-protein
transforming	I-protein
protein	I-protein
from	O
the	O
pathogenic	O
retrovirus	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
that	O
activates	O
nuclear	O
expression	O
of	O
the	O
NF-kappaB/Rel	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
by	O
an	O
unknown	O
mechanism	O
.	O

Tax	B-protein
expression	O
promotes	O
N-terminal	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaB	B-protein
alpha	I-protein
,	O
a	O
principal	O
cytoplasmic	O
inhibitor	O
of	O
NF-kappaB	B-protein
.	O

Our	O
studies	O
now	O
demonstrate	O
that	O
HTLV-1	O
Tax	B-protein
activates	O
the	O
recently	O
identified	O
cellular	B-protein
kinases	I-protein
IkappaB	B-protein
kinase	I-protein
alpha	I-protein
(	O
IKKalpha	B-protein
)	O
and	O
IKKbeta	B-protein
,	O
which	O
normally	O
phosphorylate	O
IkappaB	B-protein
alpha	I-protein
on	O
both	O
of	O
its	O
N-terminal	O
regulatory	O
serines	O
in	O
response	O
to	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
and	O
interleukin-1	B-protein
(	O
IL-1	B-protein
)	O
stimulation	O
.	O

In	O
contrast	O
,	O
a	O
mutant	O
of	O
Tax	B-protein
termed	O
M22	B-protein
,	O
which	O
does	O
not	O
induce	O
NF-kappaB	B-protein
,	O
fails	O
to	O
activate	O
either	O
IKKalpha	B-protein
or	O
IKKbeta	B-protein
.	O

Furthermore	O
,	O
endogenous	O
IKK	O
enzymatic	O
activity	O
was	O
significantly	O
elevated	O
in	O
HTLV-1-infected	B-cell_line
and	I-cell_line
Tax-expressing	I-cell_line
T-cell	I-cell_line
lines	I-cell_line
.	O

Transfection	O
of	O
kinase-deficient	O
mutants	O
of	O
IKKalpha	B-protein
and	O
IKKbeta	B-protein
into	O
either	O
human	B-cell_line
Jurkat	I-cell_line
T	I-cell_line
or	I-cell_line
293	I-cell_line
cells	I-cell_line
also	O
inhibits	O
NF-kappaB	B-protein
-dependent	O
reporter	B-DNA
gene	I-DNA
expression	O
induced	O
by	O
Tax	B-protein
.	O

Similarly	O
,	O
a	O
kinase-deficient	B-protein
mutant	I-protein
of	O
NIK	B-protein
(	O
NF-kappaB-inducing	B-protein
kinase	I-protein
)	O
,	O
which	O
represents	O
an	O
upstream	O
kinase	O
in	O
the	O
TNF-alpha	O
and	O
IL-1	O
signaling	O
pathways	O
leading	O
to	O
IKKalpha	B-protein
and	O
IKKbeta	B-protein
activation	O
,	O
blocks	O
Tax	B-protein
induction	O
of	O
NF-kappaB	B-protein
.	O

However	O
,	O
plasma	B-DNA
membrane-proximal	I-DNA
elements	I-DNA
in	O
these	O
proinflammatory	B-protein
cytokine	I-protein
pathways	O
are	O
apparently	O
not	O
involved	O
since	O
dominant	O
negative	O
mutants	O
of	O
the	O
TRAF2	B-protein
and	I-protein
TRAF6	I-protein
adaptors	I-protein
,	O
which	O
effectively	O
block	O
signaling	O
through	O
the	O
cytoplasmic	B-protein
tails	I-protein
of	O
the	O
TNF-alpha	B-protein
and	O
IL-1	B-protein
receptors	O
,	O
respectively	O
,	O
do	O
not	O
inhibit	O
Tax	B-protein
induction	O
of	O
NF-kappaB	B-protein
.	O

Together	O
,	O
these	O
studies	O
demonstrate	O
that	O
HTLV-1	O
Tax	B-protein
exploits	O
a	O
distal	O
part	O
of	O
the	O
proinflammatory	B-protein
cytokine	I-protein
signaling	O
cascade	O
leading	O
to	O
induction	O
of	O
NF-kappaB	B-protein
.	O

The	O
pathological	O
alteration	O
of	O
this	O
cytokine	O
pathway	O
leading	O
to	O
NF-kappaB	B-protein
activation	O
by	O
Tax	B-protein
may	O
play	O
a	O
central	O
role	O
in	O
HTLV-1-mediated	O
transformation	O
of	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
clinically	O
manifested	O
as	O
the	O
adult	O
T-cell	O
leukemia	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Sept.	NULL
1998	NULL
,	NULL
p.	NULL
5157-5165	NULL
0270-7306/98/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

9	NULL
Copyright	NULL
©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
Tax	NULL
Induction	NULL
of	NULL
Involves	NULL
Activation	NULL
of	NULL
the	NULL
IxB	NULL
Kinase	NULL
«	NULL
(	NULL
IKKa	NULL
)	NULL
and	NULL
IKKB	NULL
Cellular	NULL
Kinases	NULL
ROMAS	NULL
GELEZIUNAS	NULL
,	NULL
'*	NULL
SHARON	NULL
FERRELL	NULL
,	NULL
'	NULL
XIN	NULL
LIN	NULL
,	NULL
``	NULL
YAJUN	NULL
MU	NULL
,	NULL
EMMETT	NULL
T.	NULL
CUNNINGHAM	NULL
,	NULL
JR.	NULL
,	NULL
MARK	NULL
GRANT	NULL
,	NULL
``	NULL
MARGERY	NULL
A.	NULL
CONNELLY	NULL
,	NULL
``	NULL
JOHN	NULL
E.	NULL
HAMBOR	NULL
,	NULL
*	NULL
KENNETH	NULL
B.	NULL
MARCU	NULL
,	NULL
``	NULL
anp	NULL
WARNER	NULL
C	NULL
.	NULL

GREENE	NULL
!	NULL

*	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
and	NULL
Departments	NULL
of	NULL
Medicine	NULL
,	NULL
Microbiology	NULL
,	NULL
and	NULL
Immunology*	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94141-9100	NULL
;	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
State	NULL
University	NULL
of	NULL
New	NULL
York	NULL
at	NULL
Stony	NULL
Brook	NULL
,	NULL
Stony	NULL
Brook	NULL
,	NULL
New	NULL
York	NULL
11794-5215	NULL
``	NULL
;	NULL
and	NULL
Central	NULL
Research	NULL
Division	NULL
,	NULL
Pfizer	NULL
Inc.	NULL
,	NULL
Groton	NULL
,	NULL
Connecticut	NULL
06340°	NULL
Received	NULL
20	NULL
January	NULL
1998/Returned	NULL
for	NULL
modification	NULL
7	NULL
March	NULL
1998/Accepted	NULL
2	NULL
June	NULL
1998	NULL
Tax	NULL
corresponds	NULL
to	NULL
a	NULL
40-kDa	NULL
transforming	NULL
protein	NULL
from	NULL
the	NULL
pathogenic	NULL
retrovirus	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
that	NULL
activates	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
NF-B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
by	NULL
an	NULL
unknown	NULL
mechanism	NULL
.	NULL

Tax	NULL
expression	NULL
promotes	NULL
N-terminal	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
a	NULL
principal	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
NF-KB	NULL
.	NULL

Our	NULL
studies	NULL
now	NULL
demonstrate	NULL
that	NULL
HTLV-1	NULL
Tax	NULL
activates	NULL
the	NULL
recently	NULL
identified	NULL
cellular	NULL
kinases	NULL
IB	NULL
kinase	NULL
«	NULL
(	NULL
IKKa	NULL
)	NULL
and	NULL
IKK	NULL
,	NULL
which	NULL
normally	NULL
phosphorylate	NULL
IxBa	NULL
on	NULL
both	NULL
of	NULL
its	NULL
N-terminal	NULL
regulatory	NULL
serines	NULL
in	NULL
response	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
INF-	NULL
«	NULL
)	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
mutant	NULL
of	NULL
Tax	NULL
termed	NULL
M22	NULL
,	NULL
which	NULL
does	NULL
not	NULL
induce	NULL
NF-KB	NULL
,	NULL
fails	NULL
to	NULL
activate	NULL
either	NULL
IKKa	NULL
«	NULL
or	NULL
IKKB	NULL
.	NULL

Furthermore	NULL
,	NULL
endogenous	NULL
IKK	NULL
enzymatic	NULL
activity	NULL
was	NULL
significantly	NULL
elevated	NULL
in	NULL
HTLV-1-infected	NULL
and	NULL
Tax-expressing	NULL
T-cell	NULL
lines	NULL
.	NULL

Transfection	NULL
of	NULL
kinase-deficient	NULL
mutants	NULL
of	NULL
IKKa	NULL
«	NULL
and	NULL
IKKB	NULL
into	NULL
either	NULL
human	NULL
Jurkat	NULL
T	NULL
or	NULL
293	NULL
cells	NULL
also	NULL
inhibits	NULL
reporter	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
Tax	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
kinase-deficient	NULL
mutant	NULL
of	NULL
NIK	NULL
(	NULL
NF-KB-inducing	NULL
kinase	NULL
)	NULL
,	NULL
which	NULL
represents	NULL
an	NULL
upstream	NULL
kinase	NULL
in	NULL
the	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
IKKa	NULL
and	NULL
IKKf	NULL
activation	NULL
,	NULL
blocks	NULL
Tax	NULL
induction	NULL
of	NULL
NF-KB	NULL
.	NULL

However	NULL
,	NULL
plasma	NULL
membrane-proximal	NULL
elements	NULL
in	NULL
these	NULL
proinflammatory	NULL
cytokine	NULL
pathways	NULL
are	NULL
apparently	NULL
not	NULL
involved	NULL
since	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
the	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
adaptors	NULL
,	NULL
which	NULL
effectively	NULL
block	NULL
signaling	NULL
through	NULL
the	NULL
cytoplasmic	NULL
tails	NULL
of	NULL
the	NULL
TNF-a	NULL
@	NULL
and	NULL
IL-1	NULL
receptors	NULL
,	NULL
respectively	NULL
,	NULL
do	NULL
not	NULL
inhibit	NULL
Tax	NULL
induction	NULL
of	NULL
NF-KB	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
studies	NULL
demonstrate	NULL
that	NULL
HTLV-1	NULL
Tax	NULL
exploits	NULL
a	NULL
distal	NULL
part	NULL
of	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
signaling	NULL
cascade	NULL
leading	NULL
to	NULL
induction	NULL
of	NULL
NF-KB	NULL
.	NULL

The	NULL
pathological	NULL
alteration	NULL
of	NULL
this	NULL
cytokine	NULL
pathway	NULL
leading	NULL
to	NULL
NF-KB	NULL
activation	NULL
by	NULL
Tax	NULL
may	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
HTLV-1-mediated	NULL
transformation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
clinically	NULL
manifested	NULL
as	NULL
the	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
represents	NULL
the	NULL
first	NULL
pathogenic	NULL
human	NULL
retrovirus	NULL
identified	NULL
(	NULL
49	NULL
,	NULL
78	NULL
)	NULL
.	NULL

After	NULL
a	NULL
long	NULL
latency	NULL
period	NULL
,	NULL
approximately	NULL
0.05	NULL
to	NULL
0.1	NULL
%	NULL
of	NULL
individuals	NULL
infected	NULL
with	NULL
this	NULL
retrovirus	NULL
develop	NULL
an	NULL
often	NULL
aggressive	NULL
and	NULL
fatal	NULL
proliferation	NULL
of	NULL
activated	NULL
CD3	NULL
¢	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
termed	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
(	NULL
66	NULL
)	NULL
.	NULL

HTLV-1	NULL
has	NULL
also	NULL
been	NULL
etiologically	NULL
linked	NULL
with	NULL
a	NULL
progressive	NULL
neurodegenerative	NULL
syndrome	NULL
termed	NULL
HTLV-1-associated	NULL
myelopathy/tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
13	NULL
,	NULL
46	NULL
)	NULL
.	NULL

HTLV-1	NULL
encodes	NULL
a	NULL
40-kDa	NULL
regulatory	NULL
protein	NULL
termed	NULL
Tax	NULL
that	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
cell	NULL
transformation	NULL
(	NULL
18	NULL
,	NULL
36	NULL
,	NULL
50	NULL
,	NULL
58	NULL
,	NULL
64	NULL
,	NULL
74	NULL
)	NULL
.	NULL

Although	NULL
Tax	NULL
does	NULL
not	NULL
bind	NULL
directly	NULL
to	NULL
DNA	NULL
,	NULL
it	NULL
alters	NULL
the	NULL
activity	NULL
of	NULL
several	NULL
host	NULL
transcription	NULL
factors	NULL
,	NULL
notably	NULL
cyclic	NULL
AMP	NULL
responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
/activating	NULL
transcription	NULL
factor	NULL
(	NULL
ATF	NULL
)	NULL
,	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
,	NULL
and	NULL
NF-kB/Rel	NULL
(	NULL
79	NULL
)	NULL
.	NULL

Tax-induced	NULL
transactiva-tion	NULL
of	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
CREB/ATF	NULL
pathway	NULL
(	NULL
5	NULL
,	NULL
15	NULL
,	NULL
63	NULL
)	NULL
.	NULL

In	NULL
this	NULL
response	NULL
,	NULL
Tax	NULL
participates	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
that	NULL
includes	NULL
the	NULL
viral	NULL
CREs	NULL
and	NULL
CREB	NULL
,	NULL
appears	NULL
to	NULL
enhance	NULL
CREB	NULL
*	NULL
Corresponding	NULL
author	NULL
:	NULL
Mailing	NULL
address	NULL
:	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
419100	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94141-9100	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
695-3825	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
826-1514	NULL
.	NULL

E-mail	NULL
:	NULL
Romas_Geleziunas	NULL
@	NULL
quickmail.ucsf.edu	NULL
.	NULL

5157	NULL
dimerization	NULL
,	NULL
and	NULL
stabilizes	NULL
CREB	NULL
binding	NULL
to	NULL
the	NULL
CREs	NULL
(	NULL
3	NULL
,	NULL
6	NULL
,	NULL
48	NULL
,	NULL
63	NULL
,	NULL
69	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
indirectly	NULL
tethered	NULL
Tax	NULL
protein	NULL
facilitates	NULL
recruitment	NULL
of	NULL
the	NULL
transcriptional	NULL
coactivator	NULL
CREB	NULL
binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
,	NULL
through	NULL
an	NULL
interplay	NULL
with	NULL
the	NULL
KIX	NULL
domain	NULL
of	NULL
CBP	NULL
(	NULL
16	NULL
,	NULL
28	NULL
,	NULL
76	NULL
)	NULL
.	NULL

Tax	NULL
also	NULL
modulates	NULL
transcription	NULL
of	NULL
various	NULL
cellular	NULL
genes	NULL
,	NULL
some	NULL
of	NULL
which	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
T-cell	NULL
transformation	NULL
(	NULL
19	NULL
,	NULL
57	NULL
,	NULL
77	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Tax	NULL
induces	NULL
various	NULL
cytokines	NULL
and	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
via	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
(	NULL
19	NULL
,	NULL
57	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Tax	NULL
also	NULL
induces	NULL
the	NULL
c-fos	NULL
oncogene	NULL
through	NULL
SRF	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
Tax	NULL
induction	NULL
of	NULL
the	NULL
CREB/ATF	NULL
,	NULL
SRF	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B/Rel	NULL
pathways	NULL
is	NULL
selectively	NULL
impaired	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
site	NULL
directed	NULL
mutations	NULL
into	NULL
Tax	NULL
(	NULL
36	NULL
,	NULL
55	NULL
,	NULL
56	NULL
,	NULL
74	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
M22	NULL
mutant	NULL
of	NULL
Tax	NULL
(	NULL
T1308	NULL
L131	NULL
)	NULL
retains	NULL
CREB/ATF-stimulatory	NULL
activity	NULL
but	NULL
is	NULL
strongly	NULL
impaired	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
NF-kB	NULL
(	NULL
56	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
different	NULL
subre-gion	NULL
domains	NULL
of	NULL
Tax	NULL
mediate	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
various	NULL
host	NULL
transcription	NULL
factor	NULL
pathways	NULL
.	NULL

The	NULL
precise	NULL
role	NULL
of	NULL
each	NULL
of	NULL
these	NULL
pathways	NULL
in	NULL
Tax-induced	NULL
cellular	NULL
transformation	NULL
remains	NULL
unresolved	NULL
(	NULL
36	NULL
,	NULL
58	NULL
,	NULL
74	NULL
)	NULL
.	NULL

The	NULL
prototypical	NULL
NF-	NULL
«	NULL
kB	NULL
complex	NULL
corresponds	NULL
to	NULL
a	NULL
hetero-dimer	NULL
of	NULL
the	NULL
p50	NULL
(	NULL
NFKB1	NULL
)	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
members	NULL
of	NULL
the	NULL
NF-kB/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Other	NULL
5158	NULL
GELEZIUNAS	NULL
ET	NULL
AL	NULL
.	NULL

factors	NULL
in	NULL
this	NULL
family	NULL
include	NULL
RelB	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p52	NULL
(	NULL
NFKB2	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
activation	NULL
,	NULL
NF-kB	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
its	NULL
physical	NULL
interaction	NULL
with	NULL
a	NULL
set	NULL
of	NULL
inhibitors	NULL
termed	NULL
the	NULL
IxBs	NULL
(	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
)	NULL
,	NULL
p105	NULL
and	NULL
p100	NULL
(	NULL
NFKB2	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
cell	NULL
with	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
[	NULL
TNF-	NULL
«	NULL
]	NULL
and	NULL
interleukin-1	NULL
[	NULL
IL-1	NULL
]	NULL
)	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
lipopolysaccharide	NULL
,	NULL
and	NULL
several	NULL
other	NULL
activators	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
IkBa	NULL
on	NULL
two	NULL
N-terminal	NULL
serine	NULL
residues	NULL
located	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
.	NULL

This	NULL
posttranslational	NULL
modification	NULL
targets	NULL
the	NULL
inhibitor	NULL
for	NULL
rapid	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
within	NULL
the	NULL
268	NULL
proteasome	NULL
.	NULL

The	NULL
proteolysis	NULL
of	NULL
cytoplasmic	NULL
IxBa	NULL
allows	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
68	NULL
)	NULL
.	NULL

How	NULL
cytoplasmic	NULL
sequestration	NULL
of	NULL
NF-kB	NULL
by	NULL
the	NULL
p100	NULL
and	NULL
p105	NULL
inhibitors	NULL
is	NULL
relieved	NULL
remains	NULL
largely	NULL
unknown	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
has	NULL
been	NULL
a	NULL
topic	NULL
of	NULL
extensive	NULL
investigation	NULL
.	NULL

Tax	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
interact	NULL
physically	NULL
with	NULL
many	NULL
members	NULL
of	NULL
the	NULL
family	NULL
(	NULL
2	NULL
,	NULL
21	NULL
,	NULL
79	NULL
)	NULL
but	NULL
appears	NULL
to	NULL
display	NULL
highest	NULL
affinity	NULL
for	NULL
the	NULL
p100	NULL
product	NULL
of	NULL
the	NULL
NFKB2	NULL
gene	NULL
(	NULL
4	NULL
,	NULL
26	NULL
,	NULL
31	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
amino	NULL
terminus	NULL
of	NULL
p100	NULL
,	NULL
which	NULL
contains	NULL
p52	NULL
and	NULL
its	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
appears	NULL
to	NULL
mediate	NULL
this	NULL
interaction	NULL
(	NULL
4	NULL
,	NULL
26	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Tax	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
overcome	NULL
the	NULL
cytoplasmic	NULL
sequestration	NULL
property	NULL
of	NULL
p100	NULL
and	NULL
p105	NULL
,	NULL
permitting	NULL
the	NULL
release	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
26	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
convincing	NULL
series	NULL
of	NULL
studies	NULL
has	NULL
shown	NULL
that	NULL
Tax	NULL
promotes	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
HTLV-1	NULL
regulatory	NULL
protein	NULL
may	NULL
induce	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
acting	NULL
prior	NULL
to	NULL
or	NULL
at	NULL
the	NULL
level	NULL
of	NULL
IKB	NULL
phosphorylation	NULL
(	NULL
7	NULL
,	NULL
17	NULL
,	NULL
24	NULL
,	NULL
29	NULL
,	NULL
39	NULL
,	NULL
62	NULL
)	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
further	NULL
strengthened	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
degradation-resistant	NULL
IxBa	NULL
mutants	NULL
lacking	NULL
the	NULL
two	NULL
N-terminal	NULL
serine	NULL
phosphorylation	NULL
sites	NULL
effectively	NULL
block	NULL
Tax-induced	NULL
«	NULL
B-dependent	NULL
transcription	NULL
(	NULL
7	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
Tax	NULL
may	NULL
coopt	NULL
a	NULL
signaling	NULL
pathway	NULL
that	NULL
leads	NULL
to	NULL
IxB	NULL
phosphoryla-tion	NULL
.	NULL

Three	NULL
cellular	NULL
kinases	NULL
involved	NULL
in	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
induction	NULL
of	NULL
NF-kB	NULL
have	NULL
recently	NULL
been	NULL
identified	NULL
.	NULL

These	NULL
include	NULL
the	NULL
NF-kB-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
,	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
(	NULL
MAP3K	NULL
)	NULL
-related	NULL
kinase	NULL
that	NULL
associates	NULL
with	NULL
various	NULL
TNF	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
and	NULL
corresponds	NULL
to	NULL
a	NULL
strong	NULL
inducer	NULL
of	NULL
NF-kB	NULL
.	NULL

When	NULL
rendered	NULL
catalytically	NULL
inactive	NULL
,	NULL
NIK	NULL
functions	NULL
as	NULL
a	NULL
dominant-negative	NULL
inhibitor	NULL
of	NULL
TNF-	NULL
«	NULL
-	NULL
and	NULL
IL-1-induced	NULL
NF-kB	NULL
activation	NULL
(	NULL
35	NULL
,	NULL
59	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NIK	NULL
does	NULL
not	NULL
directly	NULL
phosphorylate	NULL
the	NULL
IKBs	NULL
but	NULL
instead	NULL
associates	NULL
with	NULL
and	NULL
activates	NULL
(	NULL
51	NULL
)	NULL
the	NULL
recently	NULL
recognized	NULL
IxB	NULL
kinase	NULL
a	NULL
(	NULL
IKKa	NULL
)	NULL
(	NULL
10	NULL
,	NULL
40	NULL
,	NULL
51	NULL
)	NULL
,	NULL
previously	NULL
designated	NULL
the	NULL
conserved	NULL
helix-loop-helix	NULL
ubiquitous	NULL
kinase	NULL
(	NULL
9	NULL
)	NULL
.	NULL

IKKa	NULL
«	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
both	NULL
N-terminal	NULL
serines	NULL
of	NULL
IxBa	NULL
and	NULL
preferentially	NULL
serine	NULL
23	NULL
of	NULL
IxBB	NULL
(	NULL
10	NULL
,	NULL
39	NULL
,	NULL
50	NULL
)	NULL
.	NULL

A	NULL
second	NULL
related	NULL
IKB	NULL
kinase	NULL
,	NULL
termed	NULL
IKK	NULL
$	NULL
,	NULL
has	NULL
also	NULL
been	NULL
isolated	NULL
and	NULL
characterized	NULL
(	NULL
40	NULL
,	NULL
72	NULL
,	NULL
80	NULL
)	NULL
.	NULL

This	NULL
enzyme	NULL
phosphorylates	NULL
the	NULL
regulatory	NULL
serines	NULL
of	NULL
both	NULL
IxBa	NULL
and	NULL
IxBB	NULL
.	NULL

These	NULL
«	NULL
and	NULL
B	NULL
IKKs	NULL
can	NULL
form	NULL
hetero-	NULL
and	NULL
homodimers	NULL
(	NULL
40	NULL
,	NULL
72	NULL
,	NULL
80	NULL
)	NULL
via	NULL
their	NULL
leucine	NULL
zipper	NULL
domains	NULL
,	NULL
although	NULL
heterodimers	NULL
appear	NULL
to	NULL
be	NULL
favored	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
were	NULL
aimed	NULL
at	NULL
identifying	NULL
the	NULL
cellular	NULL
signaling	NULL
intermediates	NULL
involved	NULL
in	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
Tax	NULL
activates	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
ectopically	NULL
expressed	NULL
IKKa	NULL
and	NULL
IKKB	NULL
and	NULL
that	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
endogenous	NULL
IKKs	NULL
is	NULL
elevated	NULL
in	NULL
HTLV-1-infected	NULL
and	NULL
Tax-expressing	NULL
T-cell	NULL
lines	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
report	NULL
that	NULL
kinase-deficient	NULL
versions	NULL
of	NULL
NIK	NULL
,	NULL
IKKa	NULL
,	NULL
and	NULL
IKKS	NULL
effectively	NULL
block	NULL
Tax	NULL
action	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
based	NULL
on	NULL
the	NULL
use	NULL
of	NULL
dominant	NULL
negative	NULL
mutants	NULL
,	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
involve	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

the	NULL
TRAFZ2	NULL
and	NULL
TRAF6	NULL
adaptor	NULL
proteins	NULL
which	NULL
represent	NULL
more	NULL
proximal	NULL
components	NULL
of	NULL
the	NULL
TNFa	NULL
and	NULL
IL-1	NULL
signaling	NULL
pathways	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
distal	NULL
components	NULL
of	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
signaling	NULL
pathway	NULL
are	NULL
selectively	NULL
co-opted	NULL
by	NULL
Tax	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Expression	NULL
vectors	NULL
,	NULL
biological	NULL
reagents	NULL
,	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Plasmids	NULL
pCMV4-HA-IxBa	NULL
(	NULL
SS32/36AA	NULL
)	NULL
,	NULL
«	NULL
B-TATA-luciferase	NULL
,	NULL
pCMV4Tax	NULL
,	NULL
and	NULL
pCMV4TaxM22	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
,	NULL
61	NULL
)	NULL
.	NULL

The	NULL
HTLV-1	NULL
LTR	NULL
luciferase	NULL
reporter	NULL
(	NULL
pLuc	NULL
HTLV-1	NULL
LTR	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
introducing	NULL
the	NULL
full-length	NULL
HTLV-1	NULL
LTR	NULL
into	NULL
the	NULL
pGL2-Basic	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

The	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
LTR-driven	NULL
LacZ	NULL
reporter	NULL
construct	NULL
(	NULL
6RZ	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
D.	NULL
Pearce	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
)	NULL
and	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
FLAG-TRAF2	NULL
and	NULL
dominant	NULL
negative	NULL
FLAG-TRAF2	NULL
(	NULL
87-501	NULL
)	NULL
expression	NULL
plasmids	NULL
were	NULL
provided	NULL
by	NULL
D.	NULL
V.	NULL
Goeddel	NULL
(	NULL
Tularik	NULL
Inc.	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
N-terminal	NULL
truncated	NULL
constitutively	NULL
active	NULL
MEKK1	NULL
was	NULL
provided	NULL
by	NULL
G.	NULL
L.	NULL
Johnson	NULL
(	NULL
National	NULL
Jewish	NULL
Medical	NULL
and	NULL
Research	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colo.	NULL
)	NULL
.	NULL

The	NULL
Myc-PAK1	NULL
K299R	NULL
expression	NULL
plasmid	NULL
was	NULL
provided	NULL
by	NULL
G.	NULL
M.	NULL
Bokoch	NULL
and	NULL
U.	NULL
Knaus	NULL
(	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
FLAG-JNK1	NULL
expression	NULL
vector	NULL
was	NULL
provided	NULL
by	NULL
M.	NULL
Karin	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
)	NULL
.	NULL

Murine	NULL
IKKa	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
a	NULL
previously	NULL
described	NULL
vector	NULL
(	NULL
9	NULL
)	NULL
and	NULL
subcloned	NULL
either	NULL
into	NULL
pEV3S	NULL
(	NULL
37	NULL
)	NULL
,	NULL
in	NULL
frame	NULL
with	NULL
a	NULL
C-terminal	NULL
T7	NULL
tag	NULL
to	NULL
generate	NULL
pEV-IKKa-T7	NULL
,	NULL
or	NULL
into	NULL
pcDNA	NULL
3.1	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
in	NULL
frame	NULL
with	NULL
a	NULL
C-terminal	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
epitope	NULL
tag	NULL
to	NULL
generate	NULL
peDNA-IKKa-HA	NULL
.	NULL

The	NULL
human	NULL
IKKB	NULL
cDNA	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
3	NULL
'	NULL
oligonucleo-tide	NULL
encoding	NULL
a	NULL
FLAG	NULL
epitope	NULL
tag	NULL
and	NULL
subcloned	NULL
into	NULL
peDNA3.1	NULL
to	NULL
generate	NULL
peDNA-IKKB-FLAG	NULL
.	NULL

The	NULL
TRAF6	NULL
(	NULL
289-522	NULL
)	NULL
and	NULL
NIK	NULL
cDNAs	NULL
were	NULL
generated	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
using	NULL
Jurkat	NULL
E6-1	NULL
mRNA	NULL
;	NULL
the	NULL
TRAF2	NULL
cDNA	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
the	NULL
vector	NULL
described	NULL
above	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
cDNAs	NULL
was	NULL
then	NULL
subcloned	NULL
in	NULL
frame	NULL
with	NULL
an	NULL
N-terminal	NULL
Myc	NULL
epitope	NULL
tag	NULL
in	NULL
the	NULL
pRK6	NULL
vector	NULL
.	NULL

The	NULL
kinase-deficient	NULL
K44M	NULL
IKKo	NULL
,	NULL
K44A	NULL
IKK	NULL
$	NULL
,	NULL
and	NULL
KK429/430AA	NULL
NIK	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
.	NULL

Recombinant	NULL
human	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
were	NULL
purchased	NULL
from	NULL
Endogen	NULL
(	NULL
Cam-bridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

The	NULL
293	NULL
human	NULL
embryonic	NULL
kidney	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

Jurkat	NULL
E6-1	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
the	NULL
HTLV-1-infected	NULL
T-cell	NULL
lines	NULL
C8166	NULL
and	NULL
HUT102	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

The	NULL
previously	NULL
described	NULL
(	NULL
70	NULL
)	NULL
Jurkat-Tax	NULL
and	NULL
Jurkat-anti-Tax	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
.	NULL

Transfections	NULL
and	NULL
reporter	NULL
assays	NULL
.	NULL

293	NULL
cells	NULL
(	NULL
7	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
were	NULL
seeded	NULL
into	NULL
six-well	NULL
(	NULL
35-mm-diameter	NULL
)	NULL
plates	NULL
and	NULL
transfected	NULL
the	NULL
following	NULL
day	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
DNA	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
4.25	NULL
mg	NULL
of	NULL
DNA	NULL
and	NULL
8	NULL
pl	NULL
of	NULL
DMRIE-C	NULL
(	NULL
Gibco-BRL	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

for	NULL
4	NULL
h	NULL
in	NULL
serum-free	NULL
medium	NULL
(	NULL
OPTIMEM	NULL
;	NULL
Gibco-BRL	NULL
Life	NULL
Technologies	NULL
)	NULL
in	NULL
35-mm-diameter	NULL
wells	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
18	NULL
to	NULL
24	NULL
h	NULL
later	NULL
,	NULL
using	NULL
an	NULL
enhanced	NULL
luciferase	NULL
assay	NULL
kit	NULL
and	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Mich.	NULL
)	NULL
.	NULL

All	NULL
transfections	NULL
included	NULL
the	NULL
6RZ	NULL
plasmid	NULL
to	NULL
allow	NULL
normalization	NULL
for	NULL
differences	NULL
in	NULL
gene	NULL
transfer	NULL
efficiency	NULL
by	NULL
assay	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Immune	NULL
complex	NULL
kinase	NULL
assays	NULL
.	NULL

For	NULL
the	NULL
IKK	NULL
assays	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
and	NULL
lysed	NULL
24	NULL
to	NULL
48	NULL
h	NULL
posttransfection	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
the	NULL
protease	NULL
inhibitors	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
antipain	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
aprotinin	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
5	NULL
g/	NULL
ml	NULL
)	NULL
,	NULL
pepstatin	NULL
(	NULL
0.5	NULL
g/ml	NULL
)	NULL
,	NULL
bestatin	NULL
(	NULL
7.5	NULL
pg/ml	NULL
)	NULL
,	NULL
phosphoroamidon	NULL
(	NULL
4	NULL
g/m	NULL
!	NULL
)	NULL

and	NULL
trypsin	NULL
inhibitor	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
anti-HA	NULL
monoclonal	NULL
antibody	NULL
covalently	NULL
linked	NULL
to	NULL
Sepharose	NULL
(	NULL
BABCO	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
or	NULL
anti-FLAG	NULL
M2	NULL
antibody	NULL
covalently	NULL
attached	NULL
to	NULL
agarose	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Company	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Conn.	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
lysis	NULL
buffer	NULL
and	NULL
then	NULL
once	NULL
in	NULL
kinase	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
MnCl	NULL
;	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
12.5	NULL
mM	NULL
B-glycero-2-phosphate	NULL
,	NULL
50	NULL
uM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
NaF	NULL
,	NULL
50	NULL
M	NULL
dithiothreitol	NULL
,	NULL
and	NULL
10	NULL
wM	NULL
ATP	NULL
.	NULL

To	NULL
assess	NULL
endogenous	NULL
IKKa/B	NULL
enzymatic	NULL
activity	NULL
,	NULL
25	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
anti-IKKa	NULL
antibody	NULL
H744	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
IKKB	NULL
.	NULL

After	NULL
suspension	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
kinase	NULL
buffer	NULL
,	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
mCi	NULL
of	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
(	NULL
6,000	NULL
Ci/	NULL
mmol	NULL
)	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
recombinant	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-IxBa	NULL
(	NULL
1-62	NULL
)	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
kinase	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
followed	NULL
by	NULL
transfer	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
and	NULL
exposure	NULL
to	NULL
Hyperfilm	NULL
MP	NULL
(	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
subsequently	NULL
probed	NULL
with	NULL
either	NULL
anti-HA	NULL
,	NULL
anti-FLAG	NULL
M2	NULL
,	NULL
or	NULL
anti-IKKae	NULL
H744	NULL
antibody	NULL
to	NULL
determine	NULL
the	NULL
amount	NULL
of	NULL
immunoprecipitated	NULL
kinase	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoblotted	NULL
with	NULL
peptide-specific	NULL
anti	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
IL-18V/	NULL
TNFR1	NULL
IL-1R1AcP	NULL
CDC42	NULL
Rac	NULL
TRADD	NULL
MyD88	NULL
/	NULL
\	NULL
__/	NULL
MEKK1	NULL
[	NULL
Nk	NULL
]	NULL
NO	NULL
NX	NULL
,	NULL
MKK4	NULL
[	NULL
ikke	NULL
]	NULL
[	NULL
IKKB	NULL
JNK	NULL
--	NULL
pp3Orsk	NULL
}	NULL
c-Jun	NULL
NF-	NULL
«	NULL
B	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Overview	NULL
of	NULL
the	NULL
identified	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
JNK	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Question	NULL
marks	NULL
indicate	NULL
points	NULL
in	NULL
these	NULL
signaling	NULL
cascades	NULL
that	NULL
require	NULL
confirmation	NULL
.	NULL

Components	NULL
of	NULL
these	NULL
pathways	NULL
that	NULL
are	NULL
boxed	NULL
were	NULL
examined	NULL
for	NULL
their	NULL
involvement	NULL
in	NULL
HTLV-1	NULL
Tax	NULL
action	NULL
.	NULL

RIP	NULL
,	NULL
receptor-interacting	NULL
protein	NULL
.	NULL

Tax	NULL
antibodies	NULL
to	NULL
assess	NULL
the	NULL
levels	NULL
of	NULL
Tax	NULL
protein	NULL
expression	NULL
.	NULL

The	NULL
JNK1	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
except	NULL
that	NULL
(	NULL
i	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
FLAG-JNK1	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
GST-c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
was	NULL
used	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
in	NULL
the	NULL
kinase	NULL
reaction	NULL
.	NULL

RESULTS	NULL
Signaling	NULL
pathways	NULL
leading	NULL
to	NULL
JNK	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
the	NULL
recognized	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Jun	NULL
activation	NULL
is	NULL
schematically	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

TRAFZ	NULL
and	NULL
TRAF6	NULL
represent	NULL
proximal	NULL
signaling	NULL
intermediates	NULL
that	NULL
are	NULL
recruited	NULL
to	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
type	NULL
1	NULL
TNFR	NULL
(	NULL
TNFR1	NULL
)	NULL
and	NULL
the	NULL
type	NULL
1	NULL
IL-1	NULL
receptor	NULL
(	NULL
IL-1R1	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
following	NULL
ligand	NULL
binding	NULL
(	NULL
8	NULL
,	NULL
22	NULL
)	NULL
.	NULL

TRAF2	NULL
is	NULL
recruited	NULL
through	NULL
an	NULL
interaction	NULL
with	NULL
TRADD	NULL
,	NULL
while	NULL
TRAF6	NULL
appears	NULL
to	NULL
associate	NULL
with	NULL
MyD88	NULL
and	NULL
IRAK	NULL
(	NULL
IL-1	NULL
R-associated	NULL
kinase	NULL
)	NULL
(	NULL
8	NULL
,	NULL
22	NULL
,	NULL
45	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
TRAFs	NULL
are	NULL
capable	NULL
of	NULL
engaging	NULL
NIK	NULL
,	NULL
a	NULL
MAP3K-related	NULL
kinase	NULL
,	NULL
which	NULL
thus	NULL
forms	NULL
a	NULL
nexus	NULL
in	NULL
these	NULL
two	NULL
proinflammatory	NULL
cytokine	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
(	NULL
35	NULL
,	NULL
59	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
NIK	NULL
associates	NULL
with	NULL
and	NULL
activates	NULL
IKKa	NULL
and	NULL
-B	NULL
(	NULL
51	NULL
,	NULL
72	NULL
)	NULL
.	NULL

The	NULL
IKKs	NULL
phosphorylate	NULL
the	NULL
IxBs	NULL
on	NULL
two	NULL
N-terminal	NULL
serine	NULL
residues	NULL
(	NULL
10	NULL
,	NULL
40	NULL
,	NULL
51	NULL
,	NULL
72	NULL
,	NULL
80	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
of	NULL
these	NULL
inhibitors	NULL
in	NULL
the	NULL
268	NULL
proteasome	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
68	NULL
)	NULL
.	NULL

MEKK1	NULL
corresponds	NULL
to	NULL
a	NULL
second	NULL
MAP3K	NULL
that	NULL
forms	NULL
a	NULL
key	NULL
signaling	NULL
intermediate	NULL
in	NULL
the	NULL
TNFR1	NULL
pathway	NULL
leading	NULL
to	NULL
JNK	NULL
activation	NULL
.	NULL

MEKK1	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
when	NULL
ectopically	NULL
expressed	NULL
,	NULL
but	NULL
its	NULL
role	NULL
in	NULL
TNF-	NULL
«	NULL
induction	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
remains	NULL
controversial	NULL
(	NULL
20	NULL
,	NULL
32	NULL
,	NULL
34	NULL
,	NULL
59	NULL
)	NULL
.	NULL

PAK1	NULL
corresponds	NULL
to	NULL
a	NULL
kinase	NULL
that	NULL
is	NULL
activated	NULL
by	NULL
small	NULL
GTPases	NULL
of	NULL
the	NULL
Rho	NULL
family	NULL
that	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
JNK	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
involvement	NULL
of	NULL
PAK1	NULL
in	NULL
these	NULL
signaling	NULL
pathways	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
.	NULL

Finally	NULL
,	NULL
pp90	NULL
'	NULL
``	NULL
is	NULL
a	NULL
phorbol	NULL
ester-activated	NULL
kinase	NULL
,	NULL
positioned	NULL
downstream	NULL
of	NULL
the	NULL
extracellular	NULL
response	NULL
kinases	NULL
(	NULL
ERKs	NULL
)	NULL
(	NULL
60	NULL
)	NULL
,	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
directly	NULL
phosphorylate	NULL
IxBa	NULL
on	NULL
serine	NULL
32	NULL
in	NULL
vitro	NULL
and	NULL
to	NULL
induce	NULL
degradation	NULL
of	NULL
this	NULL
inhibitor	NULL
(	NULL
14	NULL
,	NULL
54	NULL
)	NULL
.	NULL

We	NULL
have	NULL
explored	NULL
the	NULL
participation	NULL
of	NULL
several	NULL
of	NULL
these	NULL
signaling	NULL
components	NULL
in	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
response	NULL
leading	NULL
to	NULL
induction	NULL
.	NULL

The	NULL
IxBa	NULL
$	NULL
$	NULL
32/36AA	NULL
mutant	NULL
blocks	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-B	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
starting	NULL
point	NULL
in	NULL
our	NULL
studies	NULL
,	NULL
we	NULL
verified	NULL
that	NULL
a	NULL
constitutive	NULL
repressor	NULL
mutant	NULL
of	NULL
IxBa	NULL
(	NULL
the	NULL
S§32/	NULL
36AA	NULL
mutant	NULL
)	NULL
,	NULL
in	NULL
which	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
were	NULL
substituted	NULL
with	NULL
alanines	NULL
,	NULL
effectively	NULL
blocked	NULL
Tax	NULL
induction	NULL
of	NULL
xB-depen-	NULL
Tax	NULL
INDUCTION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INVOLVES	NULL
IKKe	NULL
AND	NULL
IKKB	NULL
-	NULL
5159	NULL
dent	NULL
luciferase	NULL
activity	NULL
in	NULL
human	NULL
293	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
IxBa	NULL
S§32/36AA	NULL
mutant	NULL
(	NULL
25	NULL
to	NULL
400	NULL
ng	NULL
of	NULL
expression	NULL
plasmid	NULL
[	NULL
Fig	NULL
.	NULL

2AJ	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
IxBa	NULL
S§32/	NULL
36AA	NULL
mutant	NULL
functioned	NULL
as	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
Tax-induced	NULL
NF-kB	NULL
expression	NULL
.	NULL

This	NULL
finding	NULL
confirms	NULL
for	NULL
293	NULL
cells	NULL
the	NULL
results	NULL
of	NULL
prior	NULL
studies	NULL
performed	NULL
with	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
7	NULL
,	NULL
25	NULL
)	NULL
and	NULL
suggests	NULL
that	NULL
Tax	NULL
activates	NULL
NF-kB	NULL
by	NULL
entering	NULL
a	NULL
signaling	NULL
pathway	NULL
prior	NULL
to	NULL
or	NULL
at	NULL
the	NULL
level	NULL
of	NULL
IxBa	NULL
.	NULL

Kinase-deficient	NULL
mutants	NULL
of	NULL
IKKa	NULL
«	NULL
and	NULL
IKK	NULL
block	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-KB	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
both	NULL
wild-type	NULL
and	NULL
kinase-deficient	NULL
mutants	NULL
of	NULL
IKKa	NULL
(	NULL
K44M	NULL
)	NULL
and	NULL
IKKS	NULL
A	NULL
B	NULL
8	NULL
o	NULL
£	NULL
5	NULL
r	NULL
0	NULL
&	NULL
150	NULL
S	NULL
``	NULL
E	NULL
8	NULL
3	NULL
$	NULL
-	NULL
100	NULL
§	NULL
4	NULL
I	NULL
=	NULL
2	NULL
I	NULL
E	NULL
50	NULL
2	NULL
2	NULL
6	NULL
o	NULL
a	NULL
[	NULL
ea	NULL
5	NULL
\	NULL
25	NULL
100	NULL
400	NULL
z	NULL
25	NULL
100	NULL
400	NULL
25	NULL
100	NULL
400	NULL
E	NULL
A	NULL
‘	NULL
g	NULL
A	NULL
A	NULL
+1KBO	NULL
,	NULL
SS32/36AA	NULL
lal	NULL
+1KKo	NULL
:	NULL
+1IKK	NULL
$	NULL
300	NULL
0	NULL
®	NULL
&	NULL
0	NULL
a	NULL
.	NULL

8	NULL
200	NULL
cC	NULL
3	NULL
b—	NULL
3	NULL
i_1	NULL
(	NULL
J0	NULL
I	NULL
6	NULL
&	NULL
25	NULL
100	NULL
400	NULL
25	NULL
100	NULL
400	NULL
SAAF	NULL
“	NULL
i	NULL
25	NULL
100	NULL
400	NULL
25	NULL
100	NULL
400	NULL
3	NULL
+IKKo	NULL
.	NULL

K44M	NULL
+IKKo	NULL
.	NULL

+IKKB	NULL
K44A	NULL
+IKK	NULL
$	NULL
B	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
roles	NULL
of	NULL
IKKa	NULL
and	NULL
IKKB	NULL
in	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-xB	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IxBa	NULL
mutant	NULL
HA-IkBae	NULL
$	NULL
§32/36AA	NULL
,	NULL
which	NULL
fails	NULL
to	NULL
undergo	NULL
stimulus-coupled	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
,	NULL
blocks	NULL
Tax	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
293	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
xB-TATA-luciferase	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
(	NULL
-galactosidase	NULL
reporter	NULL
)	NULL
,	NULL
and	NULL
25	NULL
,	NULL
100	NULL
,	NULL
or	NULL
400	NULL
ng	NULL
of	NULL
HA-IxBa	NULL
$	NULL
$	NULL
32/36AA	NULL
.	NULL

The	NULL
total	NULL
DNA	NULL
concentration	NULL
was	NULL
held	NULL
constant	NULL
at	NULL
4	NULL
pg	NULL
by	NULL
supplementation	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
vector	NULL
.	NULL

To	NULL
control	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
represent	NULL
the	NULL
means	NULL
(	NULL
+	NULL
standard	NULL
deviations	NULL
)	NULL
derived	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

All	NULL
values	NULL
were	NULL
first	NULL
calculated	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
reporter	NULL
plasmids	NULL
only	NULL
.	NULL

These	NULL
values	NULL
were	NULL
then	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
response	NULL
obtained	NULL
with	NULL
Tax	NULL
alone	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfection	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
wild-type	NULL
IKKa-T7	NULL
and	NULL
IKKB-FLAG	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
«	NULL
B-luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
.	NULL

Activity	NULL
is	NULL
expressed	NULL
as	NULL
arbitrary	NULL
light	NULL
units	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Error	NULL
bars	NULL
depict	NULL
standard	NULL
deviations	NULL
obtained	NULL
from	NULL
triplicate	NULL
determinations	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Functional	NULL
effects	NULL
of	NULL
wild-type	NULL
and	NULL
kinase-deficient	NULL
forms	NULL
of	NULL
IKKa-T7	NULL
and	NULL
IKKB-FLAG	NULL
on	NULL
HTLV-1	NULL
Tax	NULL
activation	NULL
of	NULL
«	NULL
B-luciferase	NULL
activity	NULL
.	NULL

Human	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pug	NULL
of	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
xB-TATA-luciferase	NULL
plasmid	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
,	NULL
and	NULL
25	NULL
,	NULL
100	NULL
,	NULL
or	NULL
400	NULL
ng	NULL
of	NULL
either	NULL
the	NULL
wild-type	NULL
IKKs	NULL
or	NULL
the	NULL
kinase-deficient	NULL
mutant	NULL
of	NULL
IKKa-T7	NULL
(	NULL
K44M	NULL
)	NULL
or	NULL
IKKB-FLAG	NULL
(	NULL
K44A	NULL
)	NULL
.	NULL

«	NULL
B-dependent	NULL
luciferase	NULL
activity	NULL
is	NULL
depicted	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
response	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
alone	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
inset	NULL
depicts	NULL
the	NULL
level	NULL
of	NULL
Tax	NULL
protein	NULL
expressed	NULL
in	NULL
each	NULL
of	NULL
the	NULL
cultures	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-Tax	NULL
antibody	NULL
.	NULL

5160	NULL
GELEZIUNAS	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
180	NULL
xB	NULL
Luciferase	NULL
HTLV-I	NULL
LTR	NULL
Luciferase	NULL
xB	NULL
Luciferase	NULL
HTLV-I	NULL
LTR	NULL
Luciferase	NULL
a	NULL
C	NULL
o	NULL
a	NULL
.	NULL

8	NULL
E100	NULL
x	NULL
ol	NULL
T	NULL
2	NULL
;	NULL
so	NULL
I	NULL
*	NULL
0	NULL
®	NULL
%	NULL
4	NULL
2	NULL
x	NULL
o1	NULL
03	NULL
1	NULL
x	NULL
of	NULL
03	NULL
i	NULL
x	NULL
01	NULL
030	NULL
d	NULL
x	NULL
of	NULL
03	NULL
1	NULL
i-	NULL
i-	NULL
-	NULL
+IKKo	NULL
.	NULL

K44M	NULL
+IKKo	NULL
:	NULL
K44M	NULL
+IKKB	NULL
K44A	NULL
+1KKB	NULL
K44A	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Functional	NULL
effects	NULL
of	NULL
kinase-deficient	NULL
IKKe	NULL
and	NULL
IKKB	NULL
mutants	NULL
on	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
using	NULL
DMRIE-C	NULL
with	NULL
350	NULL
ng	NULL
of	NULL
Tax	NULL
,	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
K44M	NULL
mutant	NULL
of	NULL
IKKa-T7	NULL
or	NULL
the	NULL
K44A	NULL
mutant	NULL
of	NULL
IKKB-FLAG	NULL
,	NULL
and	NULL
500	NULL
ng	NULL
of	NULL
either	NULL
the	NULL
«	NULL
B-luciferase	NULL
or	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

Each	NULL
transfection	NULL
also	NULL
contained	NULL
250	NULL
ng	NULL
of	NULL
6RZ	NULL
and	NULL
was	NULL
supplemented	NULL
to	NULL
4.25	NULL
pg	NULL
of	NULL
DNA	NULL
with	NULL
a	NULL
pCMV4-based	NULL
CD8	NULL
expression	NULL
vector	NULL
.	NULL

Luciferase	NULL
results	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
reporters	NULL
only	NULL
and	NULL
finally	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
response	NULL
.	NULL

(	NULL
K44A	NULL
)	NULL
on	NULL
Tax-induced	NULL
NF-kB	NULL
expression	NULL
were	NULL
next	NULL
assessed	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
wild-type	NULL
IKKs	NULL
were	NULL
included	NULL
as	NULL
controls	NULL
for	NULL
their	NULL
kinase-deficient	NULL
mutant	NULL
counterparts	NULL
,	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
wild-type	NULL
IKKa	NULL
and	NULL
IKKS	NULL
were	NULL
first	NULL
evaluated	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

IKKa	NULL
produced	NULL
only	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
«	NULL
kB-luciferase	NULL
activity	NULL
at	NULL
the	NULL
highest	NULL
dose	NULL
of	NULL
expression	NULL
vector	NULL
(	NULL
400	NULL
ng	NULL
)	NULL
,	NULL
while	NULL
IKKS	NULL
mediated	NULL
a	NULL
sevenfold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
at	NULL
the	NULL
same	NULL
dose	NULL
of	NULL
expression	NULL
vector	NULL
(	NULL
400	NULL
ng	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
either	NULL
the	NULL
IKKa	NULL
(	NULL
KA44M	NULL
)	NULL
or	NULL
IKKS	NULL
(	NULL
KA44A	NULL
)	NULL
kinase-deficient	NULL
expression	NULL
vector	NULL
produced	NULL
a	NULL
dose-dependent	NULL
suppression	NULL
of	NULL
the	NULL
Tax	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
wild-type	NULL
IKKa	NULL
and	NULL
IKKf	NULL
expression	NULL
vectors	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
Tax	NULL
response	NULL
and	NULL
in	NULL
some	NULL
cases	NULL
produced	NULL
a	NULL
slight	NULL
amplification	NULL
of	NULL
the	NULL
response	NULL
.	NULL

Immunoblotting	NULL
of	NULL
the	NULL
cell	NULL
lysates	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
comparable	NULL
levels	NULL
of	NULL
Tax	NULL
protein	NULL
expression	NULL
in	NULL
each	NULL
of	NULL
the	NULL
transfection	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
inset	NULL
)	NULL
,	NULL
eliminating	NULL
suppressive	NULL
effects	NULL
of	NULL
the	NULL
IKKa	NULL
and	NULL
IKK	NULL
kinase-deficient	NULL
mutants	NULL
on	NULL
Tax	NULL
expression	NULL
as	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
observed	NULL
inhibition	NULL
.	NULL

Kinase-deficient	NULL
IKKa	NULL
and	NULL
IKK	NULL
mutants	NULL
inhibit	NULL
HTLV-1	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
HTLV-1	NULL
preferentially	NULL
infects	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
in	NULL
some	NULL
cases	NULL
leads	NULL
to	NULL
ATL	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
kinase-deficient	NULL
mutants	NULL
of	NULL
IKKa	NULL
and	NULL
IKKB	NULL
on	NULL
Tax	NULL
induction	NULL
of	NULL
xB-luciferase	NULL
activity	NULL
were	NULL
evaluated	NULL
in	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
IKK	NULL
mutants	NULL
on	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
,	NULL
which	NULL
involves	NULL
the	NULL
CREB/ATF	NULL
rather	NULL
than	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
was	NULL
evaluated	NULL
in	NULL
parallel	NULL
.	NULL

Transfection	NULL
of	NULL
escalating	NULL
doses	NULL
(	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
)	NULL
of	NULL
the	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
IKKa	NULL
(	NULL
KA44M	NULL
)	NULL
or	NULL
IKKB	NULL
(	NULL
K44A	NULL
)	NULL
resulted	NULL
in	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
Tax	NULL
activation	NULL
of	NULL
xB-luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
over	NULL
these	NULL
same	NULL
doses	NULL
,	NULL
the	NULL
kinase-deficient	NULL
IKK	NULL
mutants	NULL
produced	NULL
no	NULL
significant	NULL
inhibition	NULL
of	NULL
Tax-induced	NULL
HTLV-1	NULL
LTR	NULL
luciferase	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
in	NULL
293	NULL
cells	NULL
,	NULL
involves	NULL
the	NULL
participation	NULL
of	NULL
IKKa	NULL
and	NULL
IKK	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
activates	NULL
IKKa	NULL
and	NULL
IKKRB	NULL
enzymatic	NULL
activity	NULL
.	NULL

To	NULL
independently	NULL
assess	NULL
whether	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
proceeds	NULL
through	NULL
IKKa	NULL
and	NULL
IKKB	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
Tax	NULL
,	NULL
like	NULL
TNF-	NULL
«	NULL
,	NULL
stimulates	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
IKKa	NULL
and	NULL
IKKS	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
perform	NULL
these	NULL
experiments	NULL
with	NULL
HeLa	NULL
cells	NULL
because	NULL
of	NULL
a	NULL
failure	NULL
to	NULL
observe	NULL
induction	NULL
of	NULL
IKK	NULL
enzymatic	NULL
activity	NULL
by	NULL
either	NULL
Tax	NULL
or	NULL
TNF-	NULL
«	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

This	NULL
result	NULL
most	NULL
likely	NULL
reflects	NULL
a	NULL
high	NULL
constitutive	NULL
enzymatic	NULL
activity	NULL
due	NULL
to	NULL
overexpression	NULL
of	NULL
these	NULL
kinases	NULL
.	NULL

Thus	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
IKKa	NULL
or	NULL
IKK	NULL
and	NULL
wild-type	NULL
Tax	NULL
or	NULL
the	NULL
M22	NULL
mutant	NULL
of	NULL
Tax	NULL
.	NULL

M22	NULL
Tax	NULL
fails	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
xB	NULL
expression	NULL
;	NULL
however	NULL
,	NULL
it	NULL
continues	NULL
to	NULL
activate	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
via	NULL
the	NULL
CREB/ATF	NULL
pathway	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
not	NULL
completely	NULL
misfolded	NULL
(	NULL
55	NULL
)	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
control	NULL
,	NULL
selected	NULL
cell	NULL
aliquots	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Kinase	NULL
activity	NULL
for	NULL
IKKa	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
and	NULL
IKKS	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
was	NULL
assessed	NULL
in	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
involving	NULL
immunoprecipitation	NULL
of	NULL
the	NULL
kinases	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
recombinant	NULL
GST-IxBo	NULL
(	NULL
1-62	NULL
)	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
B	NULL
,	NULL
wild-type	NULL
Tax	NULL
,	NULL
like	NULL
TNF-	NULL
«	NULL
,	NULL
but	NULL
not	NULL
M22	NULL
Tax	NULL
activated	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
the	NULL
IKKa	NULL
and	NULL
IKKS	NULL
proteins	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
immunoprecipitated	NULL
IKKa	NULL
and	NULL
IKKB	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
levels	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
,	NULL
in	NULL
each	NULL
transfection	NULL
condition	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
M22	NULL
Tax	NULL
mutant	NULL
was	NULL
consistently	NULL
expressed	NULL
at	NULL
lower	NULL
levels	NULL
than	NULL
wild-type	NULL
Tax	NULL
;	NULL
however	NULL
,	NULL
when	NULL
comparable	NULL
levels	NULL
of	NULL
protein	NULL
expression	NULL
were	NULL
examined	NULL
(	NULL
for	NULL
example	NULL
,	NULL
wild-type	NULL
Tax	NULL
at	NULL
0.1	NULL
wg	NULL
and	NULL
M22	NULL
Tax	NULL
at	NULL
A	NULL
B	NULL
&	NULL
®	NULL
C	NULL
°§Q°5	NULL
%	NULL
Q2\QQ	NULL
(	NULL
3	NULL
$	NULL
0	NULL
N	NULL
$	NULL
§3PQ	NULL
roS	NULL
-	NULL
puras	NULL
Y	NULL
pka	NULL
«	NULL
P	NULL
C\	NULL
AA	NULL
«	NULL
IPS	NULL
$	NULL
«	NULL
e	NULL
Pox	NULL
x	NULL
``	NULL
x	NULL
'	NULL
x	NULL
¢¢lxex	NULL
x	NULL
o.	NULL
alie	NULL
-C	NULL
GST-IxBo-	NULL
»	NULL
»	NULL
Wi	NULL
we	NULL
om	NULL
GST-IxBa	NULL
(	NULL
1-62	NULL
)	NULL
(	NULL
1-62	NULL
)	NULL
IKKo-HA	NULL
--	NULL
«	NULL
«	NULL
-	NULL
I	NULL
E	NULL
A	NULL
8	NULL
-	NULL
S	NULL
-Tax-	NULL
i	NULL
wa	NULL
--	NULL
Tax-	NULL
5	NULL
&	NULL
C	NULL
(	NULL
sq	NULL
D	NULL
a	NULL
&	NULL
A	NULL
4	NULL
C	NULL
6	NULL
}	NULL
a	NULL
«	NULL
0+	NULL
7,6	NULL
”	NULL
&	NULL
F	NULL
&	NULL
&	NULL
«	NULL
&	NULL
¢	NULL
y	NULL
»	NULL
&	NULL
¢	NULL
y	NULL
GST-IxBa	NULL
(	NULL
1-62	NULL
)	NULL
~	NULL
«	NULL
-	NULL
<	NULL
»	NULL
IKKO/IKKB	NULL
-	NULL
«	NULL
ous	NULL
cas	NULL
--	NULL
-	NULL
am-	NULL
wan	NULL
cme	NULL
Tax	NULL
-	NULL
coum	NULL
ques	NULL
muz	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
activates	NULL
ectopically	NULL
expressed	NULL
and	NULL
endogenous	NULL
IKKa	NULL
and	NULL
IKKB	NULL
enzymatic	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Approximately	NULL
4	NULL
X	NULL
10°	NULL
Hela	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
IKKa-HA	NULL
expression	NULL
plasmid	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
Tax	NULL
(	NULL
0.3	NULL
or	NULL
1	NULL
ug	NULL
)	NULL
or	NULL
M22	NULL
Tax	NULL
(	NULL
3	NULL
or	NULL
1	NULL
ug	NULL
)	NULL
expression	NULL
vector	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
IKKa-HA	NULL
only	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
or	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
10	NULL
min	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
immunoprecipitated	NULL
with	NULL
anti-HA	NULL
antibodies	NULL
and	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST-IxBa	NULL
(	NULL
1-62	NULL
)	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
.	NULL

Levels	NULL
of	NULL
immunoprecipitated	NULL
IKKa-HA	NULL
and	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
M22	NULL
Tax	NULL
present	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Approximately	NULL
10	NULL
``	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
900	NULL
ng	NULL
of	NULL
IKKB-FLAG	NULL
expression	NULL
plasmid	NULL
and	NULL
either	NULL
1.8	NULL
mg	NULL
of	NULL
wild-type	NULL
Tax	NULL
or	NULL
5.4	NULL
pg	NULL
of	NULL
M22	NULL
Tax	NULL
expression	NULL
vector	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
immunoprecipitated	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
antibody	NULL
and	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST-IxBa	NULL
(	NULL
1-62	NULL
)	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
.	NULL

Levels	NULL
of	NULL
immunoprecipitated	NULL
IKKB-FLAG	NULL
and	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
M22	NULL
Tax	NULL
present	NULL
in	NULL
the	NULL
lysates	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
endogenous	NULL
IKKa/B	NULL
immunoprecipitated	NULL
with	NULL
antibody	NULL
H744	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
both	NULL
enzymes	NULL
.	NULL

GST-IxBa	NULL
(	NULL
1-62	NULL
)	NULL
fusion	NULL
protein	NULL
was	NULL
added	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
,	NULL
and	NULL
activities	NULL
were	NULL
compared	NULL
for	NULL
unstimulated	NULL
and	NULL
TNF-	NULL
«	NULL
(	NULL
20	NULL
ng/ml	NULL
for	NULL
30	NULL
min	NULL
)	NULL
-induced	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
and	NULL
HTLV-1-infected	NULL
HUT102	NULL
and	NULL
C8166	NULL
T	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
or	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
sense	NULL
(	NULL
Jurkat-Tax	NULL
)	NULL
or	NULL
antisense	NULL
(	NULL
Jurkat-anti-Tax	NULL
)	NULL
expression	NULL
vector	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
H744-immunoprecipitated	NULL
endogenous	NULL
IKKo/B	NULL
proteins	NULL
and	NULL
levels	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
1	NULL
ug	NULL
)	NULL
,	NULL
wild-type	NULL
Tax	NULL
significantly	NULL
activated	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
IKKa	NULL
compared	NULL
with	NULL
the	NULL
M22	NULL
Tax	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
when	NULL
1.8	NULL
pg	NULL
of	NULL
wild-type	NULL
Tax	NULL
was	NULL
compared	NULL
to	NULL
5.4	NULL
ug	NULL
of	NULL
M22	NULL
Tax	NULL
,	NULL
a	NULL
significant	NULL
induction	NULL
in	NULL
IKK	NULL
enzymatic	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Utilization	NULL
of	NULL
a	NULL
GST	NULL
-IxBa	NULL
substrate	NULL
containing	NULL
alanine	NULL
substitutions	NULL
for	NULL
serine	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
demonstrated	NULL
that	NULL
the	NULL
measured	NULL
Tax	NULL
response	NULL
involved	NULL
phosphorylation	NULL
at	NULL
the	NULL
two	NULL
N-terminal	NULL
serine	NULL
residues	NULL
of	NULL
IkxBa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
like	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
TNF-a	NULL
,	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
but	NULL
not	NULL
M22	NULL
Tax	NULL
,	NULL
augments	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
both	NULL
IKKa	NULL
and	NULL
IKK	NULL
.	NULL

Endogenous	NULL
IKKs	NULL
are	NULL
enzymatically	NULL
more	NULL
active	NULL
in	NULL
HTLV-1-infected	NULL
T-cell	NULL
lines	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
Tax	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
Tax	NULL
also	NULL
activates	NULL
the	NULL
endogenous	NULL
IKKa	NULL
and	NULL
IKKS	NULL
enzymes	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
HTLV-1-infected	NULL
HUT102	NULL
or	NULL
C8166	NULL
T-cell	NULL
lines	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
engineered	NULL
to	NULL
stably	NULL
express	NULL
Tax	NULL
or	NULL
antisense	NULL
Tax	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Endogenous	NULL
IKKa	NULL
and	NULL
IKKB	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
these	NULL
cells	NULL
with	NULL
antibody	NULL
H744	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
both	NULL
enzymes	NULL
,	NULL
and	NULL
analyzed	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Although	NULL
somewhat	NULL
less	NULL
IKKa/B	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
HUT102	NULL
and	NULL
C8166	NULL
cells	NULL
than	NULL
from	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
,	NULL
both	NULL
HTLV-1l-infected	NULL
cell	NULL
lines	NULL
displayed	NULL
significantly	NULL
higher	NULL
levels	NULL
of	NULL
endogenous	NULL
IKKa/B	NULL
enzymatic	NULL
activity	NULL
.	NULL

Indeed	NULL
these	NULL
levels	NULL
of	NULL
activity	NULL
exceeded	NULL
that	NULL
obtained	NULL
in	NULL
Jurkat	NULL
E6-1	NULL
cells	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
.	NULL

While	NULL
the	NULL
HUT102	NULL
and	NULL
C8166	NULL
cells	NULL
expressed	NULL
large	NULL
amounts	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
other	NULL
differences	NULL
in	NULL
these	NULL
cells	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
responsible	NULL
for	NULL
the	NULL
altered	NULL
IKKa/B	NULL
activity	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
compared	NULL
Jurkat-Tax	NULL
and	NULL
Jurkat-anti-Tax	NULL
cell	NULL
lines	NULL
,	NULL
which	NULL
are	NULL
identical	NULL
except	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Although	NULL
expressing	NULL
comparable	NULL
amounts	NULL
of	NULL
IKKa/B	NULL
,	NULL
the	NULL
Jurkat-Tax	NULL
cells	NULL
displayed	NULL
moderately	NULL
increased	NULL
IKKa/B	NULL
enzymatic	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
Jurkat-anti-Tax	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

The	NULL
small	NULL
increase	NULL
in	NULL
IKK	NULL
activity	NULL
paralleled	NULL
the	NULL
relatively	NULL
low	NULL
level	NULL
of	NULL
Tax	NULL
expression	NULL
observed	NULL
in	NULL
the	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
IKKa/B	NULL
enzymatic	NULL
activity	NULL
is	NULL
constitutively	NULL
elevated	NULL
in	NULL
T-cell	NULL
lines	NULL
expressing	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Kinase-deficient	NULL
mutants	NULL
of	NULL
NIK	NULL
,	NULL
but	NULL
not	NULL
PAK1	NULL
,	NULL
inhibit	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
The	NULL
potential	NULL
involvement	NULL
of	NULL
NIK	NULL
in	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
next	NULL
evaluated	NULL
.	NULL

As	NULL
noted	NULL
,	NULL
NIK	NULL
represents	NULL
the	NULL
next	NULL
upstream	NULL
component	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
signaling	NULL
pathways	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

When	NULL
introduced	NULL
into	NULL
293	NULL
cells	NULL
alone	NULL
,	NULL
NIK	NULL
functioned	NULL
as	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
<	NULL
B-lucif-erase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
Tax	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
kinase-deficient	NULL
NIK	NULL
mutant	NULL
(	NULL
KK429/430¥AA	NULL
)	NULL
produced	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
«	NULL
B-luciferase	NULL
reporter	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
matching	NULL
amounts	NULL
of	NULL
the	NULL
wild-type	NULL
NIK	NULL
expression	NULL
vector	NULL
led	NULL
to	NULL
enhancement	NULL
rather	NULL
than	NULL
inhibition	NULL
of	NULL
the	NULL
Tax	NULL
response	NULL
.	NULL

Immunoblotting	NULL
of	NULL
the	NULL
cell	NULL
lysates	NULL
verified	NULL
the	NULL
presence	NULL
of	NULL
comparable	NULL
levels	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NIK	NULL
KK429/430AA	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
inset	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
role	NULL
of	NULL
PAK1	NULL
in	NULL
the	NULL
Tax	NULL
response	NULL
was	NULL
similarly	NULL
evaluated	NULL
.	NULL

PAK1	NULL
is	NULL
activated	NULL
by	NULL
certain	NULL
small	NULL
GTPases	NULL
of	NULL
the	NULL
Rho	NULL
family	NULL
(	NULL
Rac	NULL
and	NULL
CDC42	NULL
)	NULL
(	NULL
67	NULL
)	NULL
.	NULL

PAK1	NULL
,	NULL
like	NULL
the	NULL
small	NULL
GTPases	NULL
,	NULL
activates	NULL
JNK	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
be	NULL
a	NULL
downstream	NULL
effector	NULL
of	NULL
the	NULL
Rho	NULL
GTPases	NULL
(	NULL
27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
role	NULL
of	NULL
PAK1	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
unknown	NULL
.	NULL

Cotransfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
a	NULL
kinase-deficient	NULL
mutant	NULL
(	NULL
K299R	NULL
)	NULL
of	NULL
PAK1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Blotting	NULL
of	NULL
the	NULL
cellular	NULL
lysates	NULL
confirmed	NULL
dose-related	NULL
expression	NULL
of	NULL
PAK1	NULL
and	NULL
comparable	NULL
levels	NULL
of	NULL
Tax	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
inset	NULL
)	NULL
.	NULL

Tax	NULL
INDUCTION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INVOLVES	NULL
IKKe	NULL
AND	NULL
IKKB	NULL
-	NULL
5161	NULL
A	NULL
€	NULL
so-2	NULL
s	NULL
4	NULL
407	NULL
P	NULL
FA	NULL
§	NULL
304	NULL
£	NULL
§	NULL
204	NULL
30	NULL
B	NULL
5	NULL
<	NULL
0	NULL
o	NULL
(	NULL
£	NULL
&	NULL
25	NULL
100	NULL
400	NULL
8	NULL
A	NULL
>	NULL
«	NULL
NIK	NULL
Bwsoo	NULL
'	NULL
@	NULL
a	NULL
®	NULL
a	NULL
&	NULL
e	NULL
ee	NULL
-Tax	NULL
F	NULL
5	NULL
9	NULL
400	NULL
4	NULL
F	NULL
]	NULL
&	NULL
y	NULL
3004	NULL
(	NULL
3	NULL
200	NULL
A	NULL
iE	NULL
T	NULL
1004	NULL
0	NULL
a	NULL
o	NULL
%	NULL
25	NULL
100	NULL
400	NULL
25	NULL
100	NULL
400	NULL
``	NULL
~	NULL
h	NULL
--	NULL
-+NIK	NULL
KK429	NULL
(	NULL
430AA	NULL
+NIK	NULL
C	NULL
g	NULL
1594	NULL
xB	NULL
Luciferase	NULL
.	NULL

HTLV-I	NULL
LTR	NULL
Luciferase	NULL
C	NULL
0	NULL
a	NULL
.	NULL

$	NULL
@	NULL
1004	NULL
%	NULL
&	NULL
T	NULL
>	NULL
2	NULL
504	NULL
iT	NULL
pre	NULL
0	NULL
®	NULL
ox	NULL
0.1	NULL
03°	NULL
1	NULL
3	NULL
01	NULL
030	NULL
d	NULL
``	NULL
~	NULL
_	NULL
~	NULL
___	NULL
+NIK	NULL
KK429	NULL
(	NULL
430AA	NULL
+NIK	NULL
KK429/430AA	NULL
D	NULL
E	NULL
_	NULL
,	NULL
200	NULL
``	NULL
.=	NULL
©	NULL
g	NULL
20°	NULL
xB	NULL
Luciferase	NULL
_	NULL
HTLV-I	NULL
LTR	NULL
Luciferase	NULL
&	NULL
Kagan	NULL
5	NULL
S	NULL
w	NULL
o	NULL
>	NULL
er	NULL
we	NULL
®	NULL
-	NULL
Tax	NULL
a	NULL
.	NULL

§	NULL
$	NULL
8	NULL
&	NULL
e	NULL
x	NULL
(	NULL
E	NULL
s	NULL
i-	NULL
=	NULL
3	NULL
3	NULL
jar	NULL
E	NULL
E	NULL
T	NULL
T	NULL
e	NULL
+	NULL
g	NULL
0	NULL
x	NULL
o	NULL
3	NULL
a	NULL
x	NULL
25	NULL
100	NULL
400	NULL
1600	NULL
x	NULL
01	NULL
03	NULL
1	NULL
x	NULL
01	NULL
03	NULL
1	NULL
L	NULL
E	NULL
-	NULL
le	NULL
+PAK1	NULL
K209R	NULL
+PAK1	NULL
K2o9R	NULL
+PAK1	NULL
K299R	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Functional	NULL
effects	NULL
of	NULL
wild-type	NULL
and	NULL
kinase-deficient	NULL
NIK	NULL
on	NULL
HTLV-1	NULL
Tax-induced	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
wild-type	NULL
Myc-NIK	NULL
expression	NULL
vector	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
«	NULL
B-luciferase	NULL
re-porter	NULL
,	NULL
and	NULL
20	NULL
ng	NULL
of	NULL
the	NULL
6RZ	NULL
plasmid	NULL
;	NULL
18	NULL
to	NULL
24	NULL
h	NULL
later	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
«	NULL
B-luciferase	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Error	NULL
bars	NULL
depict	NULL
standard	NULL
deviations	NULL
obtained	NULL
for	NULL
triplicate	NULL
transfections	NULL
.	NULL

(	NULL
B	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
g	NULL
of	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
«	NULL
B-TATA-luciferase	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
,	NULL
and	NULL
25	NULL
,	NULL
100	NULL
,	NULL
or	NULL
400	NULL
ng	NULL
of	NULL
the	NULL
kinase-deficient	NULL
KK429/430AA	NULL
mutant	NULL
of	NULL
Myc-NIK	NULL
or	NULL
wild-type	NULL
Myc-NIK	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
relative	NULL
to	NULL
the	NULL
response	NULL
obtained	NULL
with	NULL
Tax	NULL
alone	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
inset	NULL
shows	NULL
the	NULL
level	NULL
of	NULL
Tax	NULL
expression	NULL
in	NULL
each	NULL
of	NULL
the	NULL
cultures	NULL
determined	NULL
by	NULL
immunoblotting	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Functional	NULL
effects	NULL
of	NULL
a	NULL
kinase-deficient	NULL
NIK	NULL
mutant	NULL
on	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
with	NULL
various	NULL
amounts	NULL
(	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
or	NULL
1	NULL
ag	NULL
)	NULL
of	NULL
the	NULL
KK429/430AA	NULL
mutant	NULL
of	NULL
Myc-NIK	NULL
and	NULL
350	NULL
ng	NULL
of	NULL
Tax	NULL
and	NULL
500	NULL
ng	NULL
of	NULL
the	NULL
or	NULL
HTLV-1	NULL
LTR	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
response	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
alone	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
same	NULL
experiment	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
B	NULL
was	NULL
performed	NULL
except	NULL
that	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
K299R	NULL
kinase-deficient	NULL
mutant	NULL
of	NULL
Myc-PAK1	NULL
.	NULL

Levels	NULL
of	NULL
Tax	NULL
and	NULL
Myc-PAK1	NULL
K299R	NULL
expressed	NULL
in	NULL
these	NULL
cultures	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
inset	NULL
.	NULL

(	NULL
E	NULL
)	NULL
The	NULL
same	NULL
experiment	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
C	NULL
was	NULL
performed	NULL
except	NULL
that	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
kinase-deficient	NULL
mutant	NULL
Myc-PAK1	NULL
K299R	NULL
.	NULL

5162	NULL
GELEZIUNAS	NULL
ET	NULL
AL	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
the	NULL
kinase-deficient	NULL
NIK	NULL
and	NULL
PAK1	NULL
mutants	NULL
on	NULL
Tax	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
were	NULL
also	NULL
assessed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
NIK	NULL
KK429/430AA	NULL
mutant	NULL
produced	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
Tax-induced	NULL
«	NULL
B-luciferase	NULL
activity	NULL
but	NULL
had	NULL
essentially	NULL
no	NULL
effect	NULL
on	NULL
Tax	NULL
induction	NULL
of	NULL
HTLV-1	NULL
LTR	NULL
luciferase	NULL
activity	NULL
,	NULL
which	NULL
occurs	NULL
independently	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
in	NULL
293	NULL
cells	NULL
,	NULL
the	NULL
kinase-deficient	NULL
PAK1	NULL
K299R	NULL
mutant	NULL
did	NULL
not	NULL
inhibit	NULL
«	NULL
B-luciferase	NULL
activity	NULL
induced	NULL
by	NULL
Tax	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
alter	NULL
the	NULL
Tax	NULL
induction	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
)	NULL
.	NULL
'	NULL

%	NULL
he	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
the	NULL
kinase-deficient	NULL
PAK1	NULL
mutant	NULL
further	NULL
supports	NULL
a	NULL
specific	NULL
effect	NULL
for	NULL
the	NULL
kinase-deficient	NULL
NIK	NULL
mutant	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
Tax	NULL
action	NULL
proceeds	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
NIK	NULL
enzymatic	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
observed	NULL
inhibitory	NULL
effects	NULL
of	NULL
the	NULL
NIK	NULL
KK429/430AA	NULL
mutant	NULL
observed	NULL
in	NULL
both	NULL
293	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
could	NULL
also	NULL
result	NULL
from	NULL
its	NULL
binding	NULL
to	NULL
and	NULL
inactivation	NULL
of	NULL
IKKs	NULL
,	NULL
making	NULL
these	NULL
latter	NULL
kinases	NULL
unresponsive	NULL
to	NULL
Tax	NULL
.	NULL

These	NULL
two	NULL
possibilities	NULL
could	NULL
be	NULL
distinguished	NULL
by	NULL
assessing	NULL
the	NULL
effects	NULL
of	NULL
Tax	NULL
on	NULL
NIK	NULL
enzymatic	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
indicate	NULL
that	NULL
ectopically	NULL
expressed	NULL
NIK	NULL
is	NULL
constitutively	NULL
active	NULL
and	NULL
not	NULL
induced	NULL
further	NULL
by	NULL
TNF-	NULL
«	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
Tax	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Resolution	NULL
of	NULL
this	NULL
issue	NULL
thus	NULL
awaits	NULL
the	NULL
development	NULL
of	NULL
an	NULL
im-munoprecipitating	NULL
anti-NIK	NULL
antibody	NULL
that	NULL
will	NULL
allow	NULL
assessment	NULL
of	NULL
endogenous	NULL
NIK	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Tax	NULL
.	NULL

Dominant	NULL
negative	NULL
mutants	NULL
of	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
fail	NULL
to	NULL
inhibit	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

TRAF2	NULL
interacts	NULL
with	NULL
TRADD	NULL
and	NULL
activates	NULL
NF-	NULL
«	NULL
kB	NULL
presumably	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
NIK	NULL
(	NULL
35	NULL
,	NULL
52	NULL
)	NULL
.	NULL

An	NULL
amino-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
TRAF2	NULL
[	NULL
TRAF2	NULL
(	NULL
87-501	NULL
)	NULL
]	NULL
,	NULL
lacking	NULL
its	NULL
RING	NULL
finger	NULL
domain	NULL
,	NULL
functions	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
inhibitor	NULL
in	NULL
the	NULL
TNF-	NULL
«	NULL
/TNFR1	NULL
signaling	NULL
pathway	NULL
,	NULL
blocking	NULL
both	NULL
NF-kB	NULL
and	NULL
JNK	NULL
activation	NULL
(	NULL
22	NULL
,	NULL
34	NULL
,	NULL
59	NULL
)	NULL
.	NULL

When	NULL
cotransfected	NULL
with	NULL
Tax	NULL
,	NULL
the	NULL
dominant	NULL
negative	NULL
TRAF2	NULL
mutant	NULL
did	NULL
not	NULL
alter	NULL
Tax	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
prior	NULL
studies	NULL
(	NULL
22	NULL
)	NULL
,	NULL
this	NULL
same	NULL
mutant	NULL
significantly	NULL
inhibited	NULL
the	NULL
TNF-	NULL
«	NULL
-in-duced	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
Tax	NULL
enters	NULL
the	NULL
TNF-a	NULL
signaling	NULL
pathway	NULL
downstream	NULL
of	NULL
TRAF2	NULL
or	NULL
perhaps	NULL
through	NULL
a	NULL
different	NULL
TRAF	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
TRAF6	NULL
is	NULL
recruited	NULL
to	NULL
IL-1R1	NULL
by	NULL
the	NULL
MyD88	NULL
adaptor	NULL
and	NULL
a	NULL
serine/thre-onine	NULL
kinase	NULL
termed	NULL
IRAK	NULL
(	NULL
8	NULL
,	NULL
45	NULL
,	NULL
71	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
that	NULL
Tax	NULL
activates	NULL
NF-kB	NULL
via	NULL
TRAF6	NULL
,	NULL
the	NULL
amino-terminal	NULL
deletion	NULL
mutant	NULL
TRAF6	NULL
(	NULL
289-522	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
Tax	NULL
.	NULL

While	NULL
the	NULL
TRAF6	NULL
dominant	NULL
negative	NULL
mutant	NULL
effectively	NULL
blocked	NULL
IL-1	NULL
signaling	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
(	NULL
8	NULL
)	NULL
,	NULL
no	NULL
significant	NULL
inhibitory	NULL
effects	NULL
were	NULL
obtained	NULL
for	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
involves	NULL
neither	NULL
TRAF2	NULL
nor	NULL
TRAF6	NULL
and	NULL
suggest	NULL
that	NULL
Tax	NULL
enters	NULL
this	NULL
proinflammatory	NULL
cytokine	NULL
signaling	NULL
pathway	NULL
downstream	NULL
of	NULL
the	NULL
site	NULL
of	NULL
action	NULL
of	NULL
these	NULL
TRAFs	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
is	NULL
a	NULL
weak	NULL
inducer	NULL
of	NULL
JNK1	NULL
enzymatic	NULL
activity	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

MEKK1	NULL
represents	NULL
another	NULL
kinase	NULL
of	NULL
the	NULL
MAP3K	NULL
level	NULL
that	NULL
acts	NULL
immediately	NULL
downstream	NULL
of	NULL
TRAF2	NULL
(	NULL
34	NULL
,	NULL
59	NULL
)	NULL
.	NULL

MEKK1	NULL
acting	NULL
through	NULL
the	NULL
stimulation	NULL
of	NULL
MKK4	NULL
is	NULL
a	NULL
critical	NULL
signaling	NULL
intermediate	NULL
for	NULL
TNF-	NULL
«	NULL
activation	NULL
of	NULL
JNK	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
the	NULL
transcription	NULL
factor	NULL
c-Jun	NULL
(	NULL
41	NULL
,	NULL
75	NULL
)	NULL
.	NULL

MEKK1	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
NF-kB	NULL
when	NULL
ectopically	NULL
expressed	NULL
,	NULL
but	NULL
its	NULL
role	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
arm	NULL
of	NULL
the	NULL
TNF-a	NULL
signaling	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
is	NULL
controversial	NULL
(	NULL
20	NULL
,	NULL
32	NULL
,	NULL
34	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Having	NULL
established	NULL
that	NULL
Tax	NULL
enters	NULL
the	NULL
TNF-	NULL
«	NULL
/TNFR1	NULL
pathway	NULL
downstream	NULL
of	NULL
TRAF2	NULL
and	NULL
perhaps	NULL
at	NULL
the	NULL
level	NULL
of	NULL
NIK	NULL
,	NULL
we	NULL
next	NULL
explored	NULL
whether	NULL
the	NULL
MEKK1-MKK4-JNK	NULL
axis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
activated	NULL
by	NULL
Tax	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
HTLV-1	NULL
Tax	NULL
activated	NULL
JNK1	NULL
enzymatic	NULL
activity	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
both	NULL
«	NULL
B-luciferase	NULL
and	NULL
FLAG-JNK	NULL
.	NULL

Co	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

200	NULL
g	NULL
200	NULL
g	NULL
5	NULL
2	NULL
a.	NULL
G	NULL
150	NULL
g	NULL
150	NULL
a	NULL
cC	NULL
A	NULL
&	NULL
3	NULL
3	NULL
199	NULL
E-	NULL
100	NULL
5	NULL
T	NULL
Es	NULL
i-	NULL
-J	NULL
w	NULL
50	NULL
E	NULL
so	NULL
o	NULL
I	NULL
®	NULL
6	NULL
0	NULL
yo	NULL
0	NULL
so	NULL
040	NULL
03001	NULL
oo	NULL
01	NULL
0304	NULL
i	NULL
o	NULL
z	NULL
-	NULL
A	NULL
A	NULL
+TRAF2	NULL
(	NULL
B7-501	NULL
)	NULL
+TRAF2	NULL
(	NULL
87-501	NULL
)	NULL
o	NULL
200	NULL
$	NULL
200	NULL
3	NULL
3	NULL
5	NULL
150	NULL
g	NULL
150	NULL
g	NULL
CC	NULL
o	NULL
is	NULL
CC	NULL
100	NULL
E-	NULL
100	NULL
~	NULL
T	NULL
-	NULL
>	NULL
_	NULL
B	NULL
so	NULL
'	NULL
:	NULL
|-	NULL
:	NULL
50	NULL
at	NULL
ut	NULL
0	NULL
&	NULL
0	NULL
0.1	NULL
0.3	NULL
1	NULL
0	NULL
A	NULL
*	NULL
z	NULL
0.1	NULL
0.3	NULL
&	NULL
+TRAFE	NULL
(	NULL
289-522	NULL
)	NULL
+TRAF6	NULL
(	NULL
298-522	NULL
)	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
on	NULL
Tax	NULL
induction	NULL
of	NULL
«	NULL
B-luciferase	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
200	NULL
ng	NULL
of	NULL
«	NULL
B-TATA-luciferase	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
,	NULL
and	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
FLAG-TRAF2	NULL
(	NULL
87-501	NULL
)	NULL
mutant	NULL
.	NULL

Approximately	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TNF-	NULL
«	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
6	NULL
h.	NULL
(	NULL
B	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
the	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
xB-TATA-luciferase	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
,	NULL
and	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
or	NULL
1	NULL
mg	NULL
of	NULL
FLAG-TRAF2	NULL
(	NULL
87-501	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
approximately	NULL
30	NULL
h	NULL
later	NULL
and	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
200	NULL
ng	NULL
of	NULL
xB-TATA-luciferase	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
,	NULL
and	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
Myc-TRAF6	NULL
(	NULL
289-522	NULL
)	NULL
mutant	NULL
.	NULL

At	NULL
approximately	NULL
24	NULL
h	NULL
posttransfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
(	NULL
D	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
g	NULL
of	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
«	NULL
B-TATA-luciferase	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
6RZ	NULL
,	NULL
and	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
Myc-TRAF6G	NULL
(	NULL
289-522	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
at	NULL
approximately	NULL
30	NULL
h	NULL
posttransfection	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
transfection	NULL
was	NULL
kept	NULL
constant	NULL
at	NULL
4	NULL
pg	NULL
by	NULL
supplementation	NULL
with	NULL
pCMV4	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
values	NULL
represent	NULL
the	NULL
means	NULL
(	NULL
+	NULL
standard	NULL
deviations	NULL
)	NULL
of	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

The	NULL
values	NULL
were	NULL
first	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
reporters	NULL
only	NULL
.	NULL

Final	NULL
values	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
,	NULL
IL-1	NULL
,	NULL
or	NULL
Tax	NULL
response	NULL
.	NULL

transfection	NULL
of	NULL
an	NULL
N-terminally	NULL
truncated	NULL
MEKK1	NULL
mutant	NULL
(	NULL
30	NULL
)	NULL
which	NULL
is	NULL
constitutively	NULL
active	NULL
led	NULL
to	NULL
substantial	NULL
activation	NULL
of	NULL
JNK1	NULL
as	NULL
assessed	NULL
by	NULL
phosphorylation	NULL
of	NULL
GST-c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
substrate	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

At	NULL
the	NULL
highest	NULL
dose	NULL
of	NULL
MEKK1	NULL
expression	NULL
vector	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
,	NULL
NF-xB	NULL
was	NULL
also	NULL
activated	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
Myc-TRAF2	NULL
or	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TNF-a	NULL
for	NULL
30	NULL
min	NULL
also	NULL
led	NULL
to	NULL
enhanced	NULL
JNK1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Myc-TRAF2	NULL
expression	NULL
as	NULL
well	NULL
as	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TNF-a	NULL
for	NULL
6	NULL
h	NULL
also	NULL
led	NULL
to	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
Tax	NULL
caused	NULL
only	NULL
a	NULL
modest	NULL
induction	NULL
of	NULL
JNK1	NULL
activation	NULL
compared	NULL
to	NULL
the	NULL
other	NULL
agonists	NULL
despite	NULL
causing	NULL
substantial	NULL
NF-kB	NULL
activation	NULL
in	NULL
these	NULL
same	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
demonstrating	NULL
a	NULL
similar	NULL
modest	NULL
induction	NULL
of	NULL
JNKI1	NULL
enzymatic	NULL
activity	NULL
by	NULL
Tax	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
23	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
NF-kB	NULL
,	NULL
Tax	NULL
does	NULL
not	NULL
significantly	NULL
activate	NULL
the	NULL
MEKK1-MKK4-JNK1	NULL
pathway	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
A	NULL
MEKKI	NULL
r	NULL
6	NULL
_-	NULL
ff	NULL
“	NULL
»	NULL
¢	NULL
6	NULL
.	NULL

f	NULL
&	NULL
4°C	NULL
}	NULL
cg	NULL
»	NULL
o°	NULL
a	NULL
65°	NULL
«	NULL
«	NULL
é	NULL
‘	NULL
GST-c-Jun	NULL
_	NULL
(	NULL
1-79	NULL
)	NULL
-	NULL
.	NULL

a	NULL
»	NULL
``	NULL
FLAG-INK1	NULL
-	NULL
am	NULL
»	NULL
dilb	NULL
aan	NULL
«	NULL
«	NULL
n	NULL
dite	NULL
«	NULL
3000	NULL
2000	NULL
1000	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
myc-TRAF2	NULL
Tax	NULL
TNFa	NULL
:	NULL
6	NULL
hrs	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
Tax	NULL
on	NULL
JNK1	NULL
enzymatic	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
500	NULL
ng	NULL
of	NULL
xB-TATA-luciferase	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
FLAG-JNK1	NULL
,	NULL
and	NULL
50	NULL
ng	NULL
of	NULL
6RZ	NULL
and	NULL
either	NULL
0.125	NULL
,	NULL
0.5	NULL
,	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
an	NULL
N-terminally	NULL
truncated	NULL
but	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
MEKKI	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
either	NULL
Myc-TRAF2	NULL
or	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Finally	NULL
,	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
reporters	NULL
only	NULL
were	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
and	NULL
6	NULL
h	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
TNF-a	NULL
per	NULL
ml	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
to	NULL
determine	NULL
luciferase	NULL
activity	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
and	NULL
were	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
antibody	NULL
.	NULL

Anti-FLAG	NULL
M2	NULL
immunoprecipitates	NULL
from	NULL
each	NULL
transfection	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST-c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
as	NULL
an	NULL
exogenous	NULL
substrate	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
reactions	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Membranes	NULL
were	NULL
subsequently	NULL
probed	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
antibody	NULL
to	NULL
establish	NULL
levels	NULL
of	NULL
immunoprecipitated	NULL
FLAG-JNK1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
«	NULL
B-luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
lysates	NULL
as	NULL
used	NULL
for	NULL
panel	NULL
A	NULL
and	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
to	NULL
control	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
relative	NULL
luciferase	NULL
activity	NULL
based	NULL
on	NULL
arbitrary	NULL
light	NULL
units	NULL
.	NULL

DISCUSSION	NULL
To	NULL
identify	NULL
the	NULL
molecular	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
underlying	NULL
HTLV-1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
,	NULL
we	NULL
have	NULL
explored	NULL
the	NULL
potential	NULL
involvement	NULL
of	NULL
several	NULL
components	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
signaling	NULL
pathways	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
kinase-deficient	NULL
forms	NULL
of	NULL
IKKa	NULL
,	NULL
IKKB	NULL
,	NULL
and	NULL
NIK	NULL
,	NULL
but	NULL
not	NULL
PAK1	NULL
,	NULL
effectively	NULL
inhibit	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
in	NULL
both	NULL
human	NULL
293	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Further	NULL
,	NULL
these	NULL
investigations	NULL
have	NULL
demonstrated	NULL
that	NULL
wild-type	NULL
Tax	NULL
enhances	NULL
both	NULL
IKKa	NULL
and	NULL
IKKB	NULL
enzymatic	NULL
activities	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
M22	NULL
Tax	NULL
mutant	NULL
,	NULL
which	NULL
manifests	NULL
a	NULL
specific	NULL
defect	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
does	NULL
not	NULL
significantly	NULL
stimulate	NULL
these	NULL
kinases	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
endogenous	NULL
IKKa	NULL
and	NULL
IKKB	NULL
enzymes	NULL
present	NULL
in	NULL
HTLV-1-infected	NULL
and	NULL
Tax-expressing	NULL
T-cell	NULL
lines	NULL
are	NULL
quite	NULL
ac-tive	NULL
.	NULL

Further	NULL
,	NULL
we	NULL
have	NULL
detected	NULL
Tax	NULL
activation	NULL
of	NULL
endogenous	NULL
IKKa/B	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
expressing	NULL
Tax	NULL
compared	NULL
with	NULL
matched	NULL
Jurkat	NULL
anti-Tax	NULL
controls	NULL
.	NULL

These	NULL
results	NULL
thus	NULL
significantly	NULL
extend	NULL
our	NULL
prior	NULL
study	NULL
in	NULL
which	NULL
we	NULL
demonstrated	NULL
the	NULL
involvement	NULL
of	NULL
pp90'*	NULL
in	NULL
phorbol	NULL
ester-	NULL
but	NULL
not	NULL
Tax-induced	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
HTLV-1	NULL
transactivator	NULL
protein	NULL
activates	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
cellular	NULL
kinases	NULL
capable	NULL
of	NULL
phosphorylating	NULL
IxBa	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
activate	NULL
the	NULL
IKKs	NULL
appears	NULL
to	NULL
be	NULL
quite	NULL
specific	NULL
since	NULL
a	NULL
parallel	NULL
pathway	NULL
which	NULL
is	NULL
initiated	NULL
by	NULL
TRAF	NULL
and	NULL
involves	NULL
MEKK1-MKK4	NULL
activation	NULL
of	NULL
JNK1	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
significantly	NULL
induced	NULL
by	NULL
Tax	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
MEKK1	NULL
has	NULL
been	NULL
proposed	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
it	NULL
seems	NULL
unlikely	NULL
that	NULL
Tax	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proceeds	NULL
through	NULL
MEKK1	NULL
.	NULL

For	NULL
this	NULL
to	NULL
occur	NULL
,	NULL
Tax	NULL
would	NULL
have	NULL
to	NULL
activate	NULL
MEKK1	NULL
in	NULL
a	NULL
manner	NULL
not	NULL
leading	NULL
to	NULL
standard	NULL
JNKI	NULL
activation	NULL
.	NULL

Tax	NULL
INDUCTION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INVOLVES	NULL
IKKe	NULL
AND	NULL
IKKB	NULL
-	NULL
5163	NULL
The	NULL
ability	NULL
of	NULL
a	NULL
kinase-deficient	NULL
form	NULL
of	NULL
NIK	NULL
to	NULL
block	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
raised	NULL
the	NULL
distinct	NULL
possibility	NULL
that	NULL
Tax	NULL
action	NULL
involved	NULL
this	NULL
component	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
signaling	NULL
cascade	NULL
.	NULL

However	NULL
,	NULL
the	NULL
high	NULL
constitutive	NULL
activity	NULL
of	NULL
this	NULL
enzyme	NULL
obtained	NULL
following	NULL
its	NULL
ectopic	NULL
expression	NULL
coupled	NULL
with	NULL
a	NULL
lack	NULL
of	NULL
response	NULL
of	NULL
the	NULL
kinase	NULL
to	NULL
TNF-	NULL
«	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
Tax	NULL
precluded	NULL
firm	NULL
assignment	NULL
of	NULL
this	NULL
enzyme	NULL
to	NULL
the	NULL
intracellular	NULL
pathway	NULL
utilized	NULL
by	NULL
Tax	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NIK	NULL
in	NULL
this	NULL
reaction	NULL
could	NULL
be	NULL
evaluated	NULL
if	NULL
an	NULL
active	NULL
inducible	NULL
form	NULL
of	NULL
endogenous	NULL
NIK	NULL
could	NULL
be	NULL
immunoprecipitated	NULL
from	NULL
cells	NULL
expressing	NULL
Tax	NULL
.	NULL

Un-fortunately	NULL
,	NULL
reagents	NULL
to	NULL
perform	NULL
such	NULL
an	NULL
experiment	NULL
are	NULL
not	NULL
available	NULL
at	NULL
the	NULL
present	NULL
time	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
can	NULL
not	NULL
completely	NULL
exclude	NULL
the	NULL
involvement	NULL
of	NULL
yet	NULL
another	NULL
MAP3K	NULL
in	NULL
the	NULL
Tax	NULL
response	NULL
whose	NULL
activity	NULL
is	NULL
inhibited	NULL
by	NULL
expression	NULL
of	NULL
kinase-deficient	NULL
NIK	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
that	NULL
both	NULL
Tax	NULL
and	NULL
NIK	NULL
possess	NULL
similar	NULL
properties	NULL
with	NULL
regard	NULL
to	NULL
activation	NULL
of	NULL
IKKs	NULL
and	NULL
JNK	NULL
.	NULL

Specifically	NULL
,	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
like	NULL
NIK	NULL
(	NULL
51	NULL
,	NULL
72	NULL
)	NULL
,	NULL
activates	NULL
both	NULL
IKKs	NULL
,	NULL
while	NULL
neither	NULL
of	NULL
these	NULL
proteins	NULL
significantly	NULL
activates	NULL
JNK1	NULL
(	NULL
23	NULL
,	NULL
59	NULL
,	NULL
73	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

While	NULL
Tax	NULL
utilizes	NULL
the	NULL
IKKa	NULL
,	NULL
IKKB	NULL
,	NULL
and	NULL
perhaps	NULL
NIK	NULL
components	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
signaling	NULL
pathways	NULL
,	NULL
more	NULL
proximal	NULL
components	NULL
of	NULL
these	NULL
pathways	NULL
,	NULL
specifically	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
,	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
Tax	NULL
induction	NULL
of	NULL
NF-xB	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
based	NULL
on	NULL
the	NULL
fact	NULL
that	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
,	NULL
which	NULL
effectively	NULL
block	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
signaling	NULL
,	NULL
respectively	NULL
,	NULL
fail	NULL
to	NULL
inhibit	NULL
Tax	NULL
induction	NULL
of	NULL
NF-kB	NULL
.	NULL

These	NULL
findings	NULL
further	NULL
suggest	NULL
that	NULL
Tax	NULL
does	NULL
not	NULL
activate	NULL
NF-kB	NULL
via	NULL
the	NULL
induced	NULL
transcription	NULL
and	NULL
autocrine	NULL
action	NULL
of	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
do	NULL
not	NULL
formally	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
Tax	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
another	NULL
cytokine	NULL
that	NULL
is	NULL
secreted	NULL
and	NULL
binds	NULL
to	NULL
a	NULL
receptor	NULL
that	NULL
functions	NULL
independently	NULL
of	NULL
TRAF2	NULL
and	NULL
TRAF6	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
stimulation	NULL
of	NULL
NIK	NULL
and	NULL
IKKs	NULL
.	NULL

It	NULL
remains	NULL
unknown	NULL
whether	NULL
Tax	NULL
subverts	NULL
the	NULL
TNF-	NULL
@	NULL
/IL-1	NULL
signaling	NULL
pathway	NULL
by	NULL
directly	NULL
interacting	NULL
with	NULL
and	NULL
activating	NULL
NIK	NULL
and/or	NULL
IKKa	NULL
or	NULL
IKKS	NULL
or	NULL
by	NULL
indirectly	NULL
altering	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
various	NULL
components	NULL
of	NULL
this	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
enhanced	NULL
levels	NULL
of	NULL
IKKs	NULL
in	NULL
HTLV-1	NULL
Tax-expressing	NULL
cell	NULL
lines	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
the	NULL
cause	NULL
of	NULL
increased	NULL
NF-KB	NULL
activity	NULL
since	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
IKKs	NULL
were	NULL
comparable	NULL
to	NULL
levels	NULL
in	NULL
cells	NULL
that	NULL
did	NULL
not	NULL
express	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

A	NULL
prior	NULL
report	NULL
indicating	NULL
that	NULL
Tax	NULL
induces	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
further	NULL
argues	NULL
against	NULL
an	NULL
indirect	NULL
effect	NULL
involving	NULL
new	NULL
gene	NULL
transcription	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Although	NULL
Tax	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
principally	NULL
a	NULL
nuclear	NULL
protein	NULL
,	NULL
it	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
4	NULL
,	NULL
26	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
Tax	NULL
avidly	NULL
binds	NULL
to	NULL
the	NULL
p100	NULL
product	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
xB2	NULL
gene	NULL
,	NULL
an	NULL
exclusively	NULL
cytoplasmic	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
4	NULL
,	NULL
26	NULL
,	NULL
31	NULL
,	NULL
44	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
may	NULL
thus	NULL
ensure	NULL
a	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
Tax	NULL
to	NULL
mediate	NULL
subsequent	NULL
activation	NULL
of	NULL
IKKa	NULL
,	NULL
IKKB	NULL
,	NULL
and	NULL
perhaps	NULL
NIK	NULL
.	NULL

If	NULL
Tax	NULL
does	NULL
in	NULL
fact	NULL
act	NULL
in	NULL
a	NULL
direct	NULL
manner	NULL
at	NULL
the	NULL
level	NULL
of	NULL
NIK	NULL
,	NULL
our	NULL
findings	NULL
raise	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
Tax	NULL
functions	NULL
as	NULL
a	NULL
TRAF-like	NULL
molecule	NULL
.	NULL

The	NULL
TRAFs	NULL
may	NULL
act	NULL
by	NULL
producing	NULL
oligomerization	NULL
of	NULL
the	NULL
downstream	NULL
kinase	NULL
,	NULL
leading	NULL
to	NULL
altered	NULL
enzymatic	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
M22	NULL
mutant	NULL
of	NULL
Tax	NULL
,	NULL
which	NULL
fails	NULL
to	NULL
activate	NULL
IKKa	NULL
and	NULL
IKKB	NULL
catalytic	NULL
activities	NULL
,	NULL
also	NULL
fails	NULL
to	NULL
dimerize	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
Tax	NULL
may	NULL
function	NULL
through	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
TRAF	NULL
to	NULL
promote	NULL
aggregation	NULL
of	NULL
NIK	NULL
.	NULL

Indeed	NULL
,	NULL
biological	NULL
precedence	NULL
exists	NULL
for	NULL
such	NULL
a	NULL
mechanism	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
transforming	NULL
LMP1	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
TRAFs	NULL
and	NULL
to	NULL
induce	NULL
NF-kB	NULL
(	NULL
42	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
LMP1	NULL
causes	NULL
aggregation	NULL
of	NULL
TRAFs	NULL
and	NULL
may	NULL
mimic	NULL
the	NULL
effects	NULL
of	NULL
TNF	NULL
binding	NULL
to	NULL
its	NULL
trimeric	NULL
receptor	NULL
(	NULL
42	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
Tax	NULL
induces	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
5164	NULL
GELEZIUNAS	NULL
ET	NULL
AL	NULL
.	NULL

by	NULL
altering	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
NIK	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
NIK	NULL
expression	NULL
levels	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
NF-kB	NULL
activation	NULL
(	NULL
35	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

SA	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Tax	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
unknown	NULL
activator	NULL
of	NULL
the	NULL
NIK	NULL
or	NULL
IKK	NULL
enzymes	NULL
or	NULL
perhaps	NULL
down-regulates	NULL
the	NULL
expression	NULL
or	NULL
activity	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
these	NULL
kinases	NULL
such	NULL
as	NULL
protein	NULL
phosphatase	NULL
2A	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
help	NULL
delineate	NULL
which	NULL
of	NULL
these	NULL
mechanisms	NULL
of	NULL
action	NULL
is	NULL
utilized	NULL
by	NULL
Tax	NULL
.	NULL

In	NULL
terms	NULL
of	NULL
the	NULL
biology	NULL
of	NULL
HTLV-1	NULL
infection	NULL
,	NULL
Tax	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
virally	NULL
infected	NULL
T	NULL
cells	NULL
may	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
cellular	NULL
transformation	NULL
leading	NULL
to	NULL
the	NULL
ATL	NULL
.	NULL

One	NULL
possible	NULL
role	NULL
for	NULL
Tax-induced	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
would	NULL
be	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
infected	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
expression	NULL
is	NULL
induced	NULL
by	NULL
transforming	NULL
Ras	NULL
mutants	NULL
and	NULL
that	NULL
NF-kB	NULL
production	NULL
inhibits	NULL
a	NULL
p53-independent	NULL
pathway	NULL
of	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
studies	NULL
reveal	NULL
how	NULL
HTLV-1	NULL
Tax	NULL
subverts	NULL
specific	NULL
plasma	NULL
membrane-distal	NULL
components	NULL
of	NULL
the	NULL
physiological	NULL
proinflammatory	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
the	NULL
pathologically	NULL
sustained	NULL
induction	NULL
of	NULL
NF-kB	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
provide	NULL
new	NULL
insights	NULL
into	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
Tax	NULL
action	NULL
,	NULL
emphasizing	NULL
its	NULL
ability	NULL
to	NULL
directly	NULL
or	NULL
indirectly	NULL
alter	NULL
the	NULL
activity	NULL
of	NULL
cytoplasmic	NULL
kinases	NULL
pivotally	NULL
involved	NULL
in	NULL
signal-coupled	NULL
degradation	NULL
of	NULL
IxB	NULL
.	NULL

Should	NULL
the	NULL
abnormal	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
-associated	NULL
leukemogenesis	NULL
,	NULL
the	NULL
development	NULL
of	NULL
inhibitors	NULL
of	NULL
NIK	NULL
or	NULL
IKKa	NULL
and	NULL
IKKB	NULL
might	NULL
serve	NULL
not	NULL
only	NULL
as	NULL
anti-inflammatory	NULL
agents	NULL
but	NULL
also	NULL
as	NULL
novel	NULL
chemotherapeutics	NULL
potentially	NULL
active	NULL
against	NULL
HTLV-1-induced	NULL
ATL	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
R.G	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
a	NULL
Centennial	NULL
Fellowship	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
.	NULL

E.T.C	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
NIH	NULL
grant	NULL
KO8-EY00352	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
UCSF	NULL
Center	NULL
for	NULL
AIDS	NULL
Research	NULL
(	NULL
P30A127763	NULL
)	NULL
and	NULL
from	NULL
Pfizer	NULL
.	NULL

R.G	NULL
.	NULL

,	NULL
S.F	NULL
.	NULL

,	NULL
and	NULL
XL	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

We	NULL
thank	NULL
G.	NULL
Bokoch	NULL
and	NULL
U.	NULL
Knaus	NULL
for	NULL
providing	NULL
the	NULL
PAK1	NULL
K299R	NULL
expression	NULL
vector	NULL
,	NULL
D.	NULL
Goeddel	NULL
for	NULL
the	NULL
TRAF2	NULL
and	NULL
TRAF2	NULL
(	NULL
87-501	NULL
)	NULL
vectors	NULL
,	NULL
G.	NULL
Johnson	NULL
for	NULL
the	NULL
MEKK1	NULL
vector	NULL
,	NULL
D.	NULL
Pearce	NULL
for	NULL
the	NULL
6RZ	NULL
reporter	NULL
construct	NULL
,	NULL
M.	NULL
Karin	NULL
for	NULL
the	NULL
FLAG-JNKI1	NULL
construct	NULL
,	NULL
Christo-phe	NULL
Beraud	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
Weiduan	NULL
Xu	NULL
for	NULL
technical	NULL
support	NULL
,	NULL
and	NULL
John	NULL
Carroll	NULL
,	NULL
Neile	NULL
Shea	NULL
,	NULL
Stephen	NULL
Gonzales	NULL
,	NULL
and	NULL
Chris	NULL
Goodfel-low	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
figures	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13-20	NULL
.	NULL

2	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
I	NULL
xB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-683	NULL
.	NULL

3	NULL
.	NULL

Baranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
R.	NULL
Palmer	NULL
,	NULL
M.	NULL
K.	NULL
Hamm	NULL
,	NULL
H.	NULL
A.	NULL
Giebler	NULL
,	NULL
A.	NULL
Brauweiler	NULL
,	NULL
J.	NULL
K.	NULL
Nyborg	NULL
,	NULL
and	NULL
A.	NULL
Schepartz	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
DNA-binding	NULL
enhancement	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukaemia	NULL
virus	NULL
transactivator	NULL
Tax	NULL
.	NULL

Nature	NULL
376	NULL
:	NULL
606-608	NULL
.	NULL

4	NULL
.	NULL

Beraud	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
C.	NULL
Sun	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
associates	NULL
with	NULL
and	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
NF-xB2	NULL
p100	NULL
gene	NULL
product	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1374-1382	NULL
.	NULL

5	NULL
.	NULL

Brady	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
T.	NULL
Jeang	NULL
,	NULL
J.	NULL
Duvall	NULL
,	NULL
and	NULL
G.	NULL
Khoury	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
p40x-responsive	NULL
regulatory	NULL
sequences	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:2175-2181	NULL
.	NULL

6	NULL
.	NULL

Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Garl	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Franklin	NULL
,	NULL
H.	NULL
A.	NULL
Giebler	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
molecular	NULL
mechanism	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
latency	NULL
and	NULL
Tax	NULL
transactivation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:12814-12822	NULL
.	NULL

7	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-kB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809-2818	NULL
.	NULL

8	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Xiong	NULL
,	NULL
M.	NULL
Takeuchi	NULL
,	NULL
T.	NULL
Kurama	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRAF6	NULL
is	NULL
a	NULL
signal	NULL
transducer	NULL
for	NULL
interleukin-1	NULL
.	NULL

Nature	NULL
383:443-446	NULL
.	NULL

9	NULL
.	NULL

Connelly	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
B.	NULL
Marcu	NULL
.	NULL

1995	NULL
.	NULL

CHUK	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
and	NULL
leucine	NULL
zipper	NULL
families	NULL
of	NULL
interacting	NULL
proteins	NULL
,	NULL
contains	NULL
a	NULL
serine-threonine	NULL
kinase	NULL
catalytic	NULL
domain	NULL
.	NULL

Cell	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Res	NULL
.	NULL

41:537-549	NULL
.	NULL

10	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
cytokine-responsive	NULL
IxB	NULL
kinase	NULL
that	NULL
activates	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
388:548-554	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
P.	NULL
Sassone	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1988.	NULL
c-fos	NULL
promoter	NULL
trans-activation	NULL
by	NULL
the	NULL
tax1	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8526-8530	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Tsuchiya	NULL
,	NULL
T.	NULL
Chubjo	NULL
,	NULL
T.	NULL
Akizawa	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
HTLV-1	NULL
Tax1	NULL
with	NULL
p67SRF	NULL
causes	NULL
the	NULL
aberrant	NULL
induction	NULL
of	NULL
cellular	NULL
immediate	NULL
early	NULL
genes	NULL
through	NULL
CArG	NULL
boxes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2066-2076	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
J.	NULL
C.	NULL
Vernant	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
The	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type-I	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
ii:407-410	NULL
.	NULL

Ghoda	NULL
,	NULL
L.	NULL
,	NULL
X.	NULL
Lin	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
90-kDa	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
(	NULL
pp9Orsk	NULL
)	NULL
phosphorylates	NULL
the	NULL
N-terminal	NULL
regulatory	NULL
domain	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
stimulates	NULL
its	NULL
degradation	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:21281-21288	NULL
.	NULL

Giam	NULL
,	NULL
C.	NULL
Z.	NULL
,	NULL
and	NULL
Y.	NULL
L.	NULL
Xu	NULL
.	NULL

1989	NULL
.	NULL

HTLV-1	NULL
tax	NULL
gene	NULL
product	NULL
activates	NULL
transcription	NULL
via	NULL
pre-existing	NULL
cellular	NULL
factors	NULL
and	NULL
cAMP	NULL
responsive	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:15236-15241	NULL
.	NULL

Giebler	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
J.	NULL
E.	NULL
Loring	NULL
,	NULL
K.	NULL
van	NULL
Orden	NULL
,	NULL
M.	NULL
A.	NULL
Colgin	NULL
,	NULL
J.	NULL
E.	NULL
Garrus	NULL
,	NULL
K.	NULL
W.	NULL
Escudero	NULL
,	NULL
A.	NULL
Brauweiler	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1997	NULL
.	NULL

Anchoring	NULL
of	NULL
CREB	NULL
binding	NULL
protein	NULL
to	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
:	NULL
a	NULL
molecular	NULL
mechanism	NULL
of	NULL
Tax	NULL
transactivation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:5156-5164	NULL
.	NULL

Good	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Sun	NULL
.	NULL

1996	NULL
.	NULL

Persistent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
involves	NULL
degradation	NULL
of	NULL
IxBB	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70	NULL
:	NULL
2730-2735	NULL
.	NULL

Grassmann	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Dengler	NULL
,	NULL
F.	NULL
I.	NULL
Muller	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
K.	NULL
McGuire	NULL
,	NULL
M.	NULL
C.	NULL
Dokhelar	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Transformation	NULL
to	NULL
continuous	NULL
growth	NULL
of	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
X-region	NULL
genes	NULL
transduced	NULL
by	NULL
a	NULL
herpesvirus	NULL
saimiri	NULL
vector	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3351-3355	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1989	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-1	NULL
and	NULL
pormal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:272-278	NULL
.	NULL

Hirano	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Osada	NULL
,	NULL
T.	NULL
Aoki	NULL
,	NULL
S.	NULL
Hirai	NULL
,	NULL
M.	NULL
Hosaka	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
and	NULL
S.	NULL
Ohno	NULL
.	NULL

1996	NULL
.	NULL

MEK	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
degradation	NULL
of	NULL
IxBae	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:13234-13238	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Petropoulos	NULL
,	NULL
and	NULL
J.	NULL
Lacoste	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
interactions	NULL
between	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B/IkB	NULL
transcription	NULL
complex	NULL
.	NULL

Virology	NULL
214:3-11	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
B.	NULL
Shu	NULL
,	NULL
M.	NULL
G.	NULL
Pan	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRADD-TRAF2	NULL
and	NULL
TRADD-FADD	NULL
interactions	NULL
define	NULL
two	NULL
distinct	NULL
TNF	NULL
receptor	NULL
1	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
84:299-308	NULL
.	NULL

Jin	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
H.	NULL
Teramoto	NULL
,	NULL
C.	NULL
Z.	NULL
Giam	NULL
,	NULL
R.	NULL
F.	NULL
Chun	NULL
,	NULL
J.	NULL
S.	NULL
Gutkind	NULL
,	NULL
and	NULL
K.	NULL
T.	NULL
Jeang	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
human	NULL
suppressor	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
1	NULL
activation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:25816-25823	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6443-6451.	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
in	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
stimulation	NULL
of	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11745-11748	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax-protein-mediated	NULL
activation	NULL
of	NULL
NF-xB	NULL
from	NULL
p100	NULL
(	NULL
NF-	NULL
«	NULL
B2	NULL
)	NULL
-inhibited	NULL
cytoplasmic	NULL
reservoirs	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:12634-12638	NULL
.	NULL

Knaus	NULL
,	NULL
U.	NULL
G.	NULL
,	NULL
S.	NULL
Morris	NULL
,	NULL
H.	NULL
J.	NULL
Dong	NULL
,	NULL
J.	NULL
Chernoff	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Bokoch	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
leukocyte	NULL
p21-activated	NULL
kinases	NULL
through	NULL
G	NULL
protein-coupled	NULL
receptors	NULL
.	NULL

Science	NULL
269:221-223	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
M.	NULL
E.	NULL
Laurance	NULL
,	NULL
J.	NULL
R.	NULL
Lundblad	NULL
,	NULL
P.	NULL
S.	NULL
Goldman	NULL
,	NULL
H.	NULL
Shih	NULL
,	NULL
L.	NULL
M.	NULL
Connor	NULL
,	NULL
S.	NULL
J.	NULL
Marriott	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1996	NULL
.	NULL

Control	NULL
of	NULL
cAMP-regulated	NULL
enhancers	NULL
by	NULL
the	NULL
viral	NULL
transactivator	NULL
Tax	NULL
through	NULL
CREB	NULL
and	NULL
the	NULL
co-activator	NULL
CBP	NULL
.	NULL

Nature	NULL
380:642-646	NULL
.	NULL

Lacoste	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Petropoulos	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
phosphorylation	NULL
and	NULL
turnover	NULL
of	NULL
IxBa	NULL
«	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
T-infected	NULL
and	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:564-569	NULL
.	NULL

Lange	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
C.	NULL
M.	NULL
Pleiman	NULL
,	NULL
A.	NULL
M.	NULL
Gardner	NULL
,	NULL
K.	NULL
J.	NULL
Blumer	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Johnson	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
divergence	NULL
in	NULL
the	NULL
MAP	NULL
kinase	NULL
regulatory	NULL
network	NULL
defined	NULL
by	NULL
MEK	NULL
kinase	NULL
and	NULL
Raf	NULL
.	NULL

Science	NULL
260:315-319	NULL
.	NULL

Lanoix	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Overproduction	NULL
of	NULL
NFKB2	NULL
(	NULL
lyt-10	NULL
)	NULL
and	NULL
c-Rel	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
HTLV-I	NULL
Tax-mediated	NULL
trans-activation	NULL
via	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signalling	NULL
pathway	NULL
.	NULL

Oncogene	NULL
9:841-852	NULL
.	NULL

Lee	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
Z.	NULL
J.	NULL
Chen	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
IxBa	NULL
kinase	NULL
complex	NULL
by	NULL
MEKK1	NULL
,	NULL
a	NULL
kinase	NULL
of	NULL
the	NULL
JNK	NULL
pathway	NULL
.	NULL

Cell	NULL
88:213-222	NULL
.	NULL

Lindholm	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
R.	NULL
L.	NULL
Reid	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1992	NULL
.	NULL

Extracellular	NULL
Taxl	NULL
protein	NULL
stimulates	NULL
tumor	NULL
necrosis	NULL
factor	NULL
beta	NULL
and	NULL
immunoglobulin	NULL
kappa	NULL
light	NULL
chain	NULL
expression	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:1294-1302	NULL
.	NULL

Liu	NULL
,	NULL
Z.	NULL
G.	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87:565-576	NULL
.	NULL

Malinin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
M.	NULL
P.	NULL
Boldin	NULL
,	NULL
A.	NULL
V.	NULL
Kovalenko	NULL
,	NULL
and	NULL
D.	NULL
Wallach	NULL
.	NULL

1997	NULL
.	NULL

MAP3K-related	NULL
kinase	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
TNF	NULL
,	NULL
CD95	NULL
and	NULL
IL-1	NULL
.	NULL

Nature	NULL
385:540-544	NULL
.	NULL

Matsumoto	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Shibata	NULL
,	NULL
J.	NULL
I.	NULL
Fujisawa	NULL
,	NULL
H.	NULL
Inoue	NULL
,	NULL
A.	NULL
Hakura	NULL
,	NULL
T.	NULL
Tsuka-	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58.	NULL
hara	NULL
,	NULL
and	NULL
M.	NULL
Fujii	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
via	NULL
two	NULL
distinct	NULL
pathways	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:4445-4451	NULL
.	NULL

Matthias	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
E.	NULL
Schreiber	NULL
,	NULL
S.	NULL
Rusconi	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Eukaryotic	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
mutant	NULL
proteins	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6418	NULL
.	NULL

Mayo	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
K.	NULL
S.	NULL
Rogers-Graham	NULL
,	NULL
S.	NULL
W.	NULL
Lowe	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

Der	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1997	NULL
.	NULL

Requirement	NULL
of	NULL
NF-kB	NULL
activation	NULL
to	NULL
suppress	NULL
p53-independent	NULL
apoptosis	NULL
induced	NULL
by	NULL
oncogenic	NULL
Ras	NULL
.	NULL

Science	NULL
278	NULL
:	NULL
1812-1815	NULL
.	NULL

McKinsey	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
M.	NULL
S.	NULL
Al	NULL
,	NULL
P.	NULL
L.	NULL
Green	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1996	NULL
.	NULL

Inactivation	NULL
of	NULL
IxBB	NULL
by	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
constitutive	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2083-2090	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
B.	NULL
W.	NULL
Murray	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
B.	NULL
L.	NULL
Bennett	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

Young	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
M.	NULL
Mann	NULL
,	NULL
A.	NULL
Manning	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-activated	NULL
IxB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-kB	NULL
activation	NULL
.	NULL

Science	NULL
278:860-866	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Lin	NULL
,	NULL
M.	NULL
McMahon	NULL
,	NULL
C.	NULL
C.	NULL
Lange	NULL
,	NULL
B.	NULL
Derijard	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
G.	NULL
L.	NULL
Johnson	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
ERK	NULL
and	NULL
JNK	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
by	NULL
Raf-1	NULL
and	NULL
MEKK	NULL
.	NULL

Science	NULL
266:1719-1723	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
T.	NULL
VanArsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389-399	NULL
.	NULL

Munoz	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
Courtois	NULL
,	NULL
P.	NULL
Veschambre	NULL
,	NULL
P.	NULL
Jalinot	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
dissociation	NULL
of	NULL
cytoplasmic	NULL
complexes	NULL
containing	NULL
p105	NULL
or	NULL
p100	NULL
but	NULL
does	NULL
not	NULL
induce	NULL
degradation	NULL
of	NULL
IxBa/MAD3	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:8035-8044	NULL
.	NULL

Murakami	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1995	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
enhances	NULL
NF-	NULL
«	NULL
B2	NULL
expression	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
products	NULL
p52	NULL
and	NULL
p100	NULL
,	NULL
but	NULL
does	NULL
not	NULL
suppress	NULL
the	NULL
inhibitory	NULL
function	NULL
of	NULL
p100	NULL
.	NULL

Virology	NULL
206:1066-1074	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
P.	NULL
Feng	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1997	NULL
.	NULL

IRAK	NULL
(	NULL
Pelle	NULL
)	NULL
family	NULL
member	NULL
IRAK-2	NULL
and	NULL
MyD88	NULL
as	NULL
proximal	NULL
mediators	NULL
of	NULL
IL-1	NULL
signaling	NULL
.	NULL

Science	NULL
278:1612-1615	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
S.	NULL
Izumo	NULL
,	NULL
N.	NULL
Ijichi	NULL
,	NULL
H.	NULL
Amitani	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
and	NULL
M.	NULL
Tara	NULL
.	NULL

1986	NULL
.	NULL

HTLV-I	NULL
associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
ii1031-1032	NULL
.	NULL

Pearce	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
K.	NULL
R.	NULL
Yamamoto	NULL
.	NULL

1993	NULL
.	NULL

Mincralocorticoid	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
activities	NULL
distinguished	NULL
by	NULL
nonreceptor	NULL
factors	NULL
at	NULL
a	NULL
composite	NULL
response	NULL
element	NULL
.	NULL

Science	NULL
259:1161-1165	NULL
.	NULL

Perini	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Wagner	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

Recognition	NULL
of	NULL
bZIP	NULL
proteins	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukaemia	NULL
virus	NULL
transactivator	NULL
Tax	NULL
.	NULL

Nature	NULL
376:602-605	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Pozzatti	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Vogel	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
fax	NULL
gene	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
ras	NULL
oncogene	NULL
to	NULL
induce	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:413-417	NULL
.	NULL

Regnier	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
H.	NULL
Y	NULL
.	NULL

Song	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
IxB	NULL
kinase	NULL
.	NULL

Cell	NULL
90:373-383	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
C.	NULL
Wong	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducers	NULL
associated	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
75	NULL
kDa	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

Cell	NULL
78:681-692	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Schouten	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
A.	NULL
C.	NULL
Vertegaal	NULL
,	NULL
S.	NULL
T.	NULL
Whiteside	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
M.	NULL
Toebes	NULL
,	NULL
J.	NULL
C.	NULL
Dorsman	NULL
,	NULL
A.	NULL
J.	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
and	NULL
A.	NULL
Zantema	NULL
.	NULL

1997	NULL
.	NULL

IxBa	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
mitogen-activated	NULL
90	NULL
kDa	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3133-3144	NULL
.	NULL

Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
T.	NULL
Jeang	NULL
.	NULL

1992	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
:	NULL
regions	NULL
necessary	NULL
for	NULL
function	NULL
determined	NULL
with	NULL
47	NULL
mutant	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7183-7192	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-I	NULL
tax	NULL
transactivator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
4	NULL
:	NULL
1875-1885	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
biology	NULL
of	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Investig	NULL
.	NULL

87:761-766	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

Type	NULL
I	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
through	NULL
the	NULL
cyclic	NULL
adenosine	NULL
mono-phosphate	NULL
response	NULL
element	NULL
binding	NULL
protein/activating	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Investig	NULL
.	NULL

88:1038-1042	NULL
.	NULL

Tax	NULL
INDUCTION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
INVOLVES	NULL
IKKe	NULL
AND	NULL
IKKB	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

5165	NULL
Song	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
C.	NULL
H.	NULL
Regnier	NULL
,	NULL
C.	NULL
J.	NULL
Kirschning	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-mediated	NULL
kinase	NULL
cascades	NULL
:	NULL
bifurcation	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
and	NULL
c-jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK/SAPK	NULL
)	NULL
pathways	NULL
at	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:9792-9796	NULL
.	NULL

Sturgill	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
L.	NULL
B.	NULL
Ray	NULL
,	NULL
E.	NULL
Erikson	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Maller	NULL
.	NULL

1988	NULL
.	NULL

Insulin-stimulated	NULL
MAP-2	NULL
kinase	NULL
phosphorylates	NULL
and	NULL
activates	NULL
ribosomal	NULL
protein	NULL
S6	NULL
kinase	NULL
II	NULL
.	NULL

Nature	NULL
334:715-718	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1996	NULL
.	NULL

Both	NULL
amino-	NULL
and	NULL
carboxy	NULL
!	NULL

-terminal	NULL
sequences	NULL
within	NULL
IxBa	NULL
regulate	NULL
its	NULL
inducible	NULL
degradation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1058-1065	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
activation	NULL
of	NULL
NF-xB/Re	NULL
!	NULL

involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
RelA	NULL
(	NULL
p63	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
cel	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
I	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
transactivator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
of	NULL
HTLV-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:610-614	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Tie	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Adya	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
dimer	NULL
with	NULL
CREB	NULL
and	NULL
the	NULL
viral	NULL
21-base-pair	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:8368-8374	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
1997	NULL
.	NULL

Human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
human	NULL
diseases	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:15-37	NULL
.	NULL

Van	NULL
Aelst	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
C.	NULL
D'Souza-Schorey	NULL
.	NULL

1997	NULL
.	NULL

Rho	NULL
GTPases	NULL
and	NULL
signaling	NULL
networks	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:2295-2322	NULL
.	NULL

Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
J.	NULL
K.	NULL
Stevenson	NULL
,	NULL
E.	NULL
M.	NULL
Schwarz	NULL
,	NULL
A.	NULL
D.	NULL
Van	NULL
,	NULL
and	NULL
S.	NULL
Miyamoto	NULL
.	NULL

1995	NULL
.	NULL

Rel/NF-	NULL
«	NULL
B/IxB	NULL
family	NULL
:	NULL
intimate	NULL
tales	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

92723-2735	NULL
.	NULL

Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1993	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
protein	NULL
stimulation	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
bZIP	NULL
proteins	NULL
by	NULL
enhancing	NULL
dimerization	NULL
.	NULL

Science	NULL
262:395-399	NULL
.	NULL

Wano	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Hosking	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

Stable	NULL
expression	NULL
of	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
activates	NULL
specific	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
growth	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:9733-9737	NULL
.	NULL

Wesche	NULL
,	NULL
H.	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
W.	NULL
Shillinglaw	NULL
,	NULL
S.	NULL
Li	NULL
,	NULL
and	NULL
Z.	NULL
Cao	NULL
.	NULL

1997	NULL
.	NULL

MyD88	NULL
:	NULL
an	NULL
adapter	NULL
that	NULL
recruits	NULL
IRAK	NULL
to	NULL
the	NULL
IL-1	NULL
receptor	NULL
complex	NULL
.	NULL

Immunity	NULL
7	NULL
:	NULL
837-847	NULL
.	NULL

Woronicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1997	NULL
.	NULL

IxB	NULL
kinase-B	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
IxB	NULL
kinase-	NULL
«	NULL
and	NULL
NIK	NULL
.	NULL

Science	NULL
278:866-869	NULL
.	NULL

Xu	NULL
,	NULL
X.	NULL
,	NULL
O.	NULL
Heidenreich	NULL
,	NULL
I.	NULL
Kitajima	NULL
,	NULL
K.	NULL
McGuire	NULL
,	NULL
Q.	NULL
Li	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
and	NULL
M.	NULL
Nerenberg	NULL
.	NULL

1996	NULL
.	NULL

Constitutively	NULL
activated	NULL
JNK	NULL
is	NULL
associated	NULL
with	NULL
HTLV-1	NULL
mediated	NULL
tumorigenesis	NULL
.	NULL

Oncogene	NULL
13:135-142	NULL
.	NULL

Yamaoka	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Inoue	NULL
,	NULL
M.	NULL
Sakurai	NULL
,	NULL
T.	NULL
Sugiyama	NULL
,	NULL
M.	NULL
Hazama	NULL
,	NULL
T.	NULL
Yamada	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1996	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
essential	NULL
for	NULL
transformation	NULL
of	NULL
rat	NULL
fibroblasts	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:873-877	NULL
.	NULL

Yan	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Dai	NULL
,	NULL
J.	NULL
C.	NULL
Deak	NULL
,	NULL
J.	NULL
M.	NULL
Kyriakis	NULL
,	NULL
L.	NULL
I.	NULL
Zon	NULL
,	NULL
J.	NULL
R.	NULL
Woodgett	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Templeton	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
by	NULL
MEKK1	NULL
phosphorylation	NULL
of	NULL
its	NULL
activator	NULL
SEK1	NULL
.	NULL

Nature	NULL
372:798-800	NULL
.	NULL

Yin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1996	NULL
.	NULL

HTLV-1	NULL
21	NULL
bp	NULL
repeat	NULL
sequences	NULL
facilitate	NULL
stable	NULL
association	NULL
between	NULL
Tax	NULL
and	NULL
CREB	NULL
to	NULL
increase	NULL
CREB	NULL
binding	NULL
affinity	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

264:20-31	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
1993	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
:	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
and	NULL
discase	NULL
.	NULL

Trends	NULL
Microbiol	NULL
.	NULL

1:131-135	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Miyoshi	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1982	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:2031-2035	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
and	NULL
H.	NULL
Hirai	NULL
.	NULL

1995	NULL
.	NULL

HTLV-1	NULL
oncopro-tein	NULL
tax	NULL
and	NULL
cellular	NULL
transcription	NULL
factors	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

193:79-89	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
M.	NULL
Delhase	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IxB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKa	NULL
and	NULL
IKKB	NULL
,	NULL
necessary	NULL
for	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Cell	NULL
91	NULL
:	NULL
243-252	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-1	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-I	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

